BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594. [PMID: 18242222 DOI: 10.1053/j.gastro.2007.11.059] [Cited by in Crossref: 1201] [Cited by in F6Publishing: 1212] [Article Influence: 85.8] [Reference Citation Analysis]
Number Citing Articles
1 Keshav N, Ammankallu R, Shashidhar, Paithankar JG, Baliga MS, Patil RK, Kudva AK, Raghu SV. Dextran sodium sulfate alters antioxidant status in the gut affecting the survival of Drosophila melanogaster. 3 Biotech 2022;12. [DOI: 10.1007/s13205-022-03349-2] [Reference Citation Analysis]
2 Siddiqui R, Mungroo MR, Alharbi AM, Alfahemi H, Khan NA. The Use of Gut Microbial Modulation Strategies as Interventional Strategies for Ageing. Microorganisms 2022;10:1869. [PMID: 36144471 DOI: 10.3390/microorganisms10091869] [Reference Citation Analysis]
3 Shi H, Guo J, Yu Q, Hou X, Liu L, Gao M, Wei L, Zhang L, Huang W, Wang Y, Liu G, Tontonoz P, Xian X. CRISPR/Cas9 based blockade of IL-10 signaling impairs lipid and tissue homeostasis to accelerate atherosclerosis. Front Immunol 2022;13:999470. [DOI: 10.3389/fimmu.2022.999470] [Reference Citation Analysis]
4 Dorofeyev A, Dorofeyeva A, Borysov A, Tolstanova G, Borisova T. Gastrointestinal health: changes of intestinal mucosa and microbiota in patients with ulcerative colitis and irritable bowel syndrome from PM2.5-polluted regions of Ukraine. Environ Sci Pollut Res Int 2022. [PMID: 36038689 DOI: 10.1007/s11356-022-22710-9] [Reference Citation Analysis]
5 Zhu S, Han M, Liu S, Fan L, Shi H, Li P. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front Cell Infect Microbiol 2022;12:953962. [DOI: 10.3389/fcimb.2022.953962] [Reference Citation Analysis]
6 Shome M, Song L, Williams S, Chung Y, Murugan V, Park JG, Faubion W, Pasha SF, Leighton JA, LaBaer J, Qiu J. Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures. World J Gastroenterol 2022; 28(30): 4089-4101 [DOI: 10.3748/wjg.v28.i30.4089] [Reference Citation Analysis]
7 Jiang K, Wang D, Su L, Liu X, Yue Q, Li B, Li K, Zhang S, Zhao L. Structural characteristics of locust bean gum hydrolysate and its alleviating effect on dextran sulfate sodium-induced colitis. Front Microbiol 2022;13:985725. [DOI: 10.3389/fmicb.2022.985725] [Reference Citation Analysis]
8 Peng W, Zhao X, Li X, Garg H. Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. BioMed Research International 2022;2022:1-8. [DOI: 10.1155/2022/1837850] [Reference Citation Analysis]
9 Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology 2022;20:362. [PMID: 35933341 DOI: 10.1186/s12951-022-01539-x] [Reference Citation Analysis]
10 Morgan NN, Duck LW, Wu J, Rujani M, Thomes PG, Elson CO, Mannon PJ. Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset. Inflamm Bowel Dis 2022:izac146. [PMID: 35931421 DOI: 10.1093/ibd/izac146] [Reference Citation Analysis]
11 Cannon AR, Shim EH, Kuprys PV, Choudhry MA. IL-22 and Lactobacillus delbrueckii mitigate alcohol-induced exacerbation of DSS-induced colitis. J Leukoc Biol 2022. [PMID: 35916052 DOI: 10.1002/JLB.4A0122-068R] [Reference Citation Analysis]
12 Cao C, Wang L, Ai C, Gong G, Wang Z, Huang L, Song S, Zhu B. Impact of Lycium barbarum arabinogalactan on the fecal metabolome in a DSS-induced chronic colitis mouse model. Food Funct 2022. [PMID: 35912853 DOI: 10.1039/d2fo01283a] [Reference Citation Analysis]
13 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Role of the Gut–Brain Axis, Gut Microbial Composition, Diet, and Probiotic Intervention in Parkinson’s Disease. Microorganisms 2022;10:1544. [DOI: 10.3390/microorganisms10081544] [Reference Citation Analysis]
14 Li S, Chen S, Nie M, Wen L, Zou B, Zhang L, Xie J, Ser H, Lee L, Wang S, Lin C, Pathak JL, Zhou W, Miao J, Wang L, Zheng L. Salt-Sensitive Ileal Microbiota Plays a Role in Atrial Natriuretic Peptide Deficiency-Induced Cardiac Injury. Nutrients 2022;14:3129. [DOI: 10.3390/nu14153129] [Reference Citation Analysis]
15 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Reference Citation Analysis]
16 Chen B, Li X, Cai T, Wang F. Short-term and long-term alterations of gastrointestinal microbiota with different H. pylori eradication regimens: A meta-analysis. Front Cell Infect Microbiol 2022;12:913384. [DOI: 10.3389/fcimb.2022.913384] [Reference Citation Analysis]
17 Nag D, Farr D, Raychaudhuri S, Withey JH. An adult zebrafish model for adherent-invasive Escherichia coli indicates protection from AIEC infection by probiotic E. coli Nissle. iScience 2022;25:104572. [PMID: 35769878 DOI: 10.1016/j.isci.2022.104572] [Reference Citation Analysis]
18 Biazzo M, Deidda G. Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. J Clin Med 2022;11:4119. [PMID: 35887883 DOI: 10.3390/jcm11144119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int J Mol Sci 2022;23:7611. [PMID: 35886959 DOI: 10.3390/ijms23147611] [Reference Citation Analysis]
20 Zhang Y, Si X, Yang L, Wang H, Sun Y, Liu N. Association between intestinal microbiota and inflammatory bowel disease. Animal Model Exp Med 2022. [PMID: 35808814 DOI: 10.1002/ame2.12255] [Reference Citation Analysis]
21 Song S, Sun H, Liu JS, Hou L. Multi-Cell-Type Openness-Weighted Association Studies for Trait-Associated Genomic Segments Prioritization. Genes 2022;13:1220. [DOI: 10.3390/genes13071220] [Reference Citation Analysis]
22 Mohammed Y, Holmes A, Kwok PCL, Kumeria T, Namjoshi S, Imran M, Matteucci L, Ali M, Tai W, Benson HAE, Roberts MS. Advances and future perspectives in epithelial drug delivery. Adv Drug Deliv Rev 2022;186:114293. [PMID: 35483435 DOI: 10.1016/j.addr.2022.114293] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Li Q, Zhou S, Wang Y, Cong J. Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 2022;204:442. [PMID: 35776212 DOI: 10.1007/s00203-022-03069-4] [Reference Citation Analysis]
24 Li W, Wang Y, Wang C, Wang H, Ma Y, Yang H, Zhao X, Hu X, Kao JY, Qian J, Owyang C, Li J. Probiotic mixture VSL#3 prevents ulcerative colitis-associated carcinogenesis in mice and cells by regulating the inflammatory and Wnt/β-catenin pathway. Chin Med J (Engl) 2022. [PMID: 35672115 DOI: 10.1097/CM9.0000000000002035] [Reference Citation Analysis]
25 Pu D, Zhang Z, Feng B. Alterations and Potential Applications of Gut Microbiota in Biological Therapy for Inflammatory Bowel Diseases. Front Pharmacol 2022;13:906419. [DOI: 10.3389/fphar.2022.906419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Takáčová M, Bomba A, Tóthová C, Micháľová A, Turňa H. Any Future for Faecal Microbiota Transplantation as a Novel Strategy for Gut Microbiota Modulation in Human and Veterinary Medicine? Life 2022;12:723. [DOI: 10.3390/life12050723] [Reference Citation Analysis]
27 Catlett JL, Carr S, Cashman M, Smith MD, Walter M, Sakkaff Z, Kelley C, Pierobon M, Cohen MB, Buan NR. Metabolic Synergy between Human Symbionts Bacteroides and Methanobrevibacter. Microbiol Spectr 2022;:e0106722. [PMID: 35536023 DOI: 10.1128/spectrum.01067-22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Młynarska E, Gadzinowska J, Tokarek J, Forycka J, Szuman A, Franczyk B, Rysz J. The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder. Nutrients 2022;14:1921. [DOI: 10.3390/nu14091921] [Reference Citation Analysis]
29 Khan I, Wei J, Li A, Liu Z, Yang P, Jing Y, Chen X, Zhao T, Bai Y, Zha L, Li C, Ullah N, Che T, Zhang C. Lactobacillus plantarum strains attenuated DSS-induced colitis in mice by modulating the gut microbiota and immune response. Int Microbiol 2022. [PMID: 35414032 DOI: 10.1007/s10123-022-00243-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Li Q, Li L, Li Q, Wang J, Nie S, Xie M. Influence of Natural Polysaccharides on Intestinal Microbiota in Inflammatory Bowel Diseases: An Overview. Foods 2022;11:1084. [DOI: 10.3390/foods11081084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chidambaram SB, Rathipriya AG, Mahalakshmi AM, Sharma S, Hediyal TA, Ray B, Sunanda T, Rungratanawanich W, Kashyap RS, Qoronfleh MW, Essa MM, Song BJ, Monaghan TM. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke. Cells 2022;11:1239. [PMID: 35406804 DOI: 10.3390/cells11071239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Lucchinetti E, Lou P, Lemal P, Bestmann L, Hersberger M, Rogler G, Krämer SD, Zaugg M. Gut microbiome and circulating bacterial DNA (“blood microbiome”) in a mouse model of total parenteral nutrition: Evidence of two distinct separate microbiotic compartments. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.03.038] [Reference Citation Analysis]
33 He P, Yu L, Tian F, Zhang H, Chen W, Zhai Q. Dietary Patterns and Gut Microbiota: the Crucial Actors in Inflammatory Bowel Disease. Adv Nutr 2022:nmac029. [PMID: 35348593 DOI: 10.1093/advances/nmac029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Segal JP. Inflammatory disease of the ileoanal pouch - is it all in the microbiome? Future Microbiol 2022;17:481-3. [PMID: 35317617 DOI: 10.2217/fmb-2022-0024] [Reference Citation Analysis]
35 Zhang F, Zhou Y, Chen H, Jiang H, Zhou F, Lv B, Xu M, Dominguez Perles R. Curcumin Alleviates DSS-Induced Anxiety-Like Behaviors via the Microbial-Brain-Gut Axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/6244757] [Reference Citation Analysis]
36 Voina-tonea A, Labunet A, Objelean A, Onisor F, Bran S, Mester A, Piciu A, Sava S. A Systematic Analysis of the Available Human Clinical Studies of Dental Implant Failure in Patients with Inflammatory Bowel Disease. Medicina 2022;58:343. [DOI: 10.3390/medicina58030343] [Reference Citation Analysis]
37 Abbas-Egbariya H, Haberman Y, Braun T, Hadar R, Denson L, Gal-Mor O, Amir A. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biol 2022;23:61. [PMID: 35197084 DOI: 10.1186/s13059-022-02637-7] [Reference Citation Analysis]
38 Liu H, Gao P, Jia B, Lu N, Zhu B, Zhang F. IBD-Associated Atg16L1T300A Polymorphism Regulates Commensal Microbiota of the Intestine. Front Immunol 2021;12:772189. [PMID: 35154071 DOI: 10.3389/fimmu.2021.772189] [Reference Citation Analysis]
39 Chiang HY, Lu HH, Sudhakar JN, Chen YW, Shih NS, Weng YT, Shui JW. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nat Commun 2022;13:874. [PMID: 35169117 DOI: 10.1038/s41467-022-28478-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Plauzolles A, Toumi E, Bonnet M, Pénaranda G, Bidaut G, Chiche L, Allardet-servent J, Retornaz F, Goutorbe B, Halfon P. Human Stool Preservation Impacts Taxonomic Profiles in 16S Metagenomics Studies. Front Cell Infect Microbiol 2022;12:722886. [DOI: 10.3389/fcimb.2022.722886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kim YC, Ham B, Kang KD, Yun JM, Kwon MJ, Kim HS, Hwang HB. Bacterial distribution on the ocular surface of patients with primary Sjögren's syndrome. Sci Rep 2022;12:1715. [PMID: 35110614 DOI: 10.1038/s41598-022-05625-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Ali I, Abdo Q, Al-hihi SM, Shawabkeh A. Association between ulcerative colitis and Helicobacter pylori infection: A case-control study. Heliyon 2022;8:e08930. [DOI: 10.1016/j.heliyon.2022.e08930] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 van der Lugt B, Vos MC, Grootte Bromhaar M, Ijssennagger N, Vrieling F, Meijerink J, Steegenga WT. The effects of sulfated secondary bile acids on intestinal barrier function and immune response in an inflammatory in vitro human intestinal model. Heliyon 2022;8:e08883. [DOI: 10.1016/j.heliyon.2022.e08883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ramires LC, Santos GS, Ramires RP, da Fonseca LF, Jeyaraman M, Muthu S, Lana AV, Azzini G, Smith CS, Lana JF. The Association between Gut Microbiota and Osteoarthritis: Does the Disease Begin in the Gut? Int J Mol Sci 2022;23:1494. [PMID: 35163417 DOI: 10.3390/ijms23031494] [Reference Citation Analysis]
45 Isidori M, Corbee RJ, Trabalza-marinucci M. Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy—A Narrative Review. Veterinary Sciences 2022;9:37. [DOI: 10.3390/vetsci9020037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kamioka M, Goto Y, Nakamura K, Yokoi Y, Sugimoto R, Ohira S, Kurashima Y, Umemoto S, Sato S, Kunisawa J, Takahashi Y, Domino SE, Renauld JC, Nakae S, Iwakura Y, Ernst PB, Ayabe T, Kiyono H. Intestinal commensal microbiota and cytokines regulate Fut2+ Paneth cells for gut defense. Proc Natl Acad Sci U S A 2022;119:e2115230119. [PMID: 35027453 DOI: 10.1073/pnas.2115230119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Mishra J, Stubbs M, Kuang L, Vara N, Kumar P, Kumar N, Subramanian VS. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mediators of Inflammation 2022;2022:1-15. [DOI: 10.1155/2022/9621668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
48 Niu W, Yang F, Fu Z, Dong Y, Zhang Z, Ju J. The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease. Microb Pathog 2021;:105381. [PMID: 34974123 DOI: 10.1016/j.micpath.2021.105381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
49 Kangale LJ, Raoult D, Fournier PE, Ghigo E. Culturomics revealed the bacterial constituents of the microbiota of a 10-year-old laboratory culture of planarian species S. mediterranea. Sci Rep 2021;11:24311. [PMID: 34934139 DOI: 10.1038/s41598-021-03719-5] [Reference Citation Analysis]
50 Hao W, Cha R, Wang M, Zhang P, Jiang X. Impact of nanomaterials on the intestinal mucosal barrier and its application in treating intestinal diseases. Nanoscale Horiz 2021;7:6-30. [PMID: 34889349 DOI: 10.1039/d1nh00315a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
51 Hill JE, Peña-Sánchez JN, Fernando C, Freitas AC, Withana Gamage N, Fowler S. Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021:izab314. [PMID: 34919692 DOI: 10.1093/ibd/izab314] [Reference Citation Analysis]
52 Minaya DM, Weinstein NL, Czaja K. Development of a 3D-Printed High Temperature Resin Cecal Fistula Implant for Long-Term and Minimally Invasive Access to the Gut Microbiome. Nutrients 2021;13:4515. [PMID: 34960067 DOI: 10.3390/nu13124515] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Lee JY, Kang W, Shin NR, Hyun DW, Kim PS, Kim HS, Lee JY, Tak EJ, Sung H, Bae JW. Anaerostipes hominis sp. nov., a novel butyrate-producing bacteria isolated from faeces of a patient with Crohn's disease. Int J Syst Evol Microbiol 2021;71. [PMID: 34870576 DOI: 10.1099/ijsem.0.005129] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Faruqui NA, Prium DH, Mowna SA, Ullah MA, Araf Y, Sarkar B, Zohora US, Rahman MS. Gut microorganisms and neurological disease perspectives. Future Neurology 2021;16:FNL53. [DOI: 10.2217/fnl-2020-0026] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Zhang Y, Zhang J, Xu T, Zhang C, Yu WQ, Wei T, Zhang B, Chen Q, Qiu JY, Li HJ, Liang TB. Role of TLR5 in the Translocation and Dissemination of Commensal Bacteria in the Intestine after Traumatic Hemorrhagic Shock. J Immunol Res 2021;2021:6417658. [PMID: 34840990 DOI: 10.1155/2021/6417658] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Steiner HE, Gee K, Giles J, Knight H, Hurwitz BL, Karnes JH. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application. Pharmacotherapy 2021. [PMID: 34820870 DOI: 10.1002/phar.2650] [Reference Citation Analysis]
57 Bakshi HA, Quinn GA, Aljabali AAA, Hakkim FL, Farzand R, Nasef MM, Abuglela N, Ansari P, Mishra V, Serrano-Aroca Á, Tambuwala MM. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals (Basel) 2021;14:1211. [PMID: 34959610 DOI: 10.3390/ph14121211] [Reference Citation Analysis]
58 Amedei A, Capasso C, Nannini G, Supuran CT. Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases? Mediators Inflamm 2021;2021:6926082. [PMID: 34803517 DOI: 10.1155/2021/6926082] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Huang S, Hu S, Liu S, Tang B, Liu Y, Tang L, Lei Y, Zhong L, Yang S, He S. Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner. Pharmacol Res 2021;175:105992. [PMID: 34801681 DOI: 10.1016/j.phrs.2021.105992] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
60 Shaler CR, Parco AA, Elhenawy W, Dourka J, Jury J, Verdu EF, Coombes BK. Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobionts. Nat Commun 2021;12:6664. [PMID: 34795263 DOI: 10.1038/s41467-021-26992-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Huang AJ, Clarke AN, Jafari N, Leung BM. Characterization of Patterned Microbial Growth Dynamics in Aqueous Two-Phase Polymer Scaffolds. ACS Biomater Sci Eng 2021. [PMID: 34757724 DOI: 10.1021/acsbiomaterials.1c01130] [Reference Citation Analysis]
62 Zhang N, Liu J, Guo X, Li S, Wang F, Wang M. Armillaria luteo-virens Sacc Ameliorates Dextran Sulfate Sodium Induced Colitis through Modulation of Gut Microbiota and Microbiota-Related Bile Acids. Nutrients 2021;13:3926. [PMID: 34836184 DOI: 10.3390/nu13113926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ran B, Wang Z, Cai W, Ran L, Xia W, Liu W, Peng X. Organic Photo-antimicrobials: Principles, Molecule Design, and Applications. J Am Chem Soc 2021;143:17891-909. [PMID: 34677069 DOI: 10.1021/jacs.1c08679] [Reference Citation Analysis]
64 Mishra V, Bose A, Kiran S, Banerjee S, Shah IA, Chaukimath P, Reshi MM, Srinivas S, Barman A, Visweswariah SS. Gut-associated cGMP mediates colitis and dysbiosis in a mouse model of an activating mutation in GUCY2C. J Exp Med 2021;218:e20210479. [PMID: 34546338 DOI: 10.1084/jem.20210479] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
65 Lluansí A, Llirós M, Oliver L, Bahí A, Elias-Masiques N, Gonzalez M, Benejam P, Cueva E, Termes M, Ramió-Pujol S, Malagón M, Amoedo J, Serrano M, Busquets D, Torreabla L, Sabat M, Buxó M, Cambra M, Serra-Pagès M, Delgado-Aros S, García-Gil LJ, Elias I, Aldeguer X. In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome. Front Microbiol 2021;12:716307. [PMID: 34707578 DOI: 10.3389/fmicb.2021.716307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Abdehagh M, Azimirad M, Houri H, Nadalian B, Azimirad F, Olfatifar M, Nasir Shoeibi OK, Yadegar A, Shahrokh S, Mahdavi Roshan M, Asadzadeh Aghdaei H, Zali MR. Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease. BMC Infect Dis 2021;21:1103. [PMID: 34702217 DOI: 10.1186/s12879-021-06804-2] [Reference Citation Analysis]
67 Sultan S, El-Mowafy M, Elgaml A, Ahmed TAE, Hassan H, Mottawea W. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease. Front Physiol 2021;12:715506. [PMID: 34646151 DOI: 10.3389/fphys.2021.715506] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
68 Ho HE, Radigan L, Bongers G, El-Shamy A, Cunningham-Rundles C. Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency. JCI Insight 2021;6:e144777. [PMID: 34622805 DOI: 10.1172/jci.insight.144777] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Han X, Ding S, Ma Y, Fang J, Jiang H, Li Y, Liu G. Lactobacillus plantarum and Lactobacillus brevis Alleviate Intestinal Inflammation and Microbial Disorder Induced by ETEC in a Murine Model. Oxid Med Cell Longev 2021;2021:6867962. [PMID: 34594475 DOI: 10.1155/2021/6867962] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
70 Pulipati P, Talukdar R. Gut microbiome linked to pancreatitis. Current Opinion in Physiology 2021;23:100470. [DOI: 10.1016/j.cophys.2021.100470] [Reference Citation Analysis]
71 Byrne LW, McKay D. Does perioperative biological therapy increase 30-day post-operative complication rates in inflammatory bowel disease patients undergoing intra-abdominal surgery? A systematic review. Surgeon 2021;19:e153-67. [PMID: 34581275 DOI: 10.1016/j.surge.2020.09.001] [Reference Citation Analysis]
72 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
73 Sibinelli-Sousa S, de Araújo-Silva AL, Hespanhol JT, Bayer-Santos E. Revisiting the steps of Salmonella gut infection with a focus on antagonistic interbacterial interactions. FEBS J 2021. [PMID: 34546626 DOI: 10.1111/febs.16211] [Reference Citation Analysis]
74 Nishikawa H, Nakamura S, Miyazaki T, Kakimoto K, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance. J Clin Med 2021;10:4214. [PMID: 34575326 DOI: 10.3390/jcm10184214] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
75 Jergens AE, Parvinroo S, Kopper J, Wannemuehler MJ. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:669913. [PMID: 34513862 DOI: 10.3389/fmed.2021.669913] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
76 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Qu W, Liu L, Miao L. Exposure to antibiotics during pregnancy alters offspring outcomes. Expert Opin Drug Metab Toxicol 2021;17:1165-74. [PMID: 34435921 DOI: 10.1080/17425255.2021.1974000] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Pan S, Hong F, Li L, Guo Y, Qiao X, Zhang J, Xu P, Zhai Y. Melatonin Attenuates Dextran Sodium Sulfate Induced Colitis in Obese Mice. Pharmaceuticals (Basel) 2021;14:822. [PMID: 34451919 DOI: 10.3390/ph14080822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Wang R, Yao Q, Chen W, Gao F, Li P, Wu J, Yu J, Cao H. Stem cell therapy for Crohn's disease: systematic review and meta-analysis of preclinical and clinical studies. Stem Cell Res Ther 2021;12:463. [PMID: 34407875 DOI: 10.1186/s13287-021-02533-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
80 Dwivedi M, Powali S, Rastogi S, Singh A, Gupta DK. Microbial community in human gut: a therapeutic prospect and implication in health and diseases. Lett Appl Microbiol 2021. [PMID: 34365651 DOI: 10.1111/lam.13549] [Reference Citation Analysis]
81 Giri S, Dutta P, Giri TK. Inulin-based carriers for colon drug targeting. Journal of Drug Delivery Science and Technology 2021;64:102595. [DOI: 10.1016/j.jddst.2021.102595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Yu L, Yu Y, Xiao Y, Tian F, Narbad A, Zhai Q, Chen W. Lead-induced gut injuries and the dietary protective strategies: A review. Journal of Functional Foods 2021;83:104528. [DOI: 10.1016/j.jff.2021.104528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Kurakula M, Gorityala S, Moharir K. Recent trends in design and evaluation of chitosan-based colon targeted drug delivery systems: Update 2020. Journal of Drug Delivery Science and Technology 2021;64:102579. [DOI: 10.1016/j.jddst.2021.102579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
84 Liu Y, Huang W, Wang J, Ma J, Zhang M, Lu X, Liu J, Kou Y. Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier. Front Immunol 2021;12:693479. [PMID: 34386004 DOI: 10.3389/fimmu.2021.693479] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Okamura Y, Kinoshita M, Kono T, Sakai M, Hikima JI. Deficiency of interleukin-17 receptor A1 induces microbiota disruption in the intestine of Japanese medaka, Oryzias latipes. Comp Biochem Physiol Part D Genomics Proteomics 2021;40:100885. [PMID: 34339936 DOI: 10.1016/j.cbd.2021.100885] [Reference Citation Analysis]
86 Tong L, Hao H, Zhang Z, Lv Y, Liang X, Liu Q, Liu T, Gong P, Zhang L, Cao F, Pastorin G, Lee CN, Chen X, Wang JW, Yi H. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota. Theranostics 2021;11:8570-86. [PMID: 34373759 DOI: 10.7150/thno.62046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
87 Levin D, De Palma G, Zou H, Bazzaz AHZ, Verdu E, Baker B, Pinto-sanchez MI, Khalidi N, Larché MJ, Beattie KA, Bercik P. Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth. Journal of Scleroderma and Related Disorders 2021;6:290-8. [DOI: 10.1177/23971983211032808] [Reference Citation Analysis]
88 Kuenstner L, Kuenstner JT. Mycobacterium avium ssp. paratuberculosis in the Food Supply: A Public Health Issue. Front Public Health 2021;9:647448. [PMID: 34336758 DOI: 10.3389/fpubh.2021.647448] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
89 Lu S, Zhu K, Guo Y, Wang E, Huang J. Evaluation of animal models of Crohn's disease with anal fistula (Review). Exp Ther Med 2021;22:974. [PMID: 34335916 DOI: 10.3892/etm.2021.10406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Crothers JW, Chu ND, Nguyen LTT, Phillips M, Collins C, Fortner K, Del Rio-Guerra R, Lavoie B, Callas P, Velez M, Cohn A, Elliott RJ, Wong WF, Vo E, Wilcox R, Smith M, Kassam Z, Budd R, Alm EJ, Mawe GM, Moses PL. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol 2021;21:281. [PMID: 34238227 DOI: 10.1186/s12876-021-01856-9] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
91 Wu L, Shen F, Wang W, Qi C, Wang C, Shang A, Xuan S. The effect of multispecies probiotics on cognitive reactivity to sad mood in patients with Crohn’s disease. Journal of Functional Foods 2021;82:104431. [DOI: 10.1016/j.jff.2021.104431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Wang G, Sun W, Pei X, Jin Y, Wang H, Tao W, Xiao Z, Liu L, Wang M. Galactooligosaccharide pretreatment alleviates damage of the intestinal barrier and inflammatory responses in LPS-challenged mice. Food Funct 2021;12:1569-79. [PMID: 33459741 DOI: 10.1039/d0fo03020a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
93 Pavel FM, Vesa CM, Gheorghe G, Diaconu CC, Stoicescu M, Munteanu MA, Babes EE, Tit DM, Toma MM, Bungau S. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Diagnostics (Basel) 2021;11:1090. [PMID: 34203609 DOI: 10.3390/diagnostics11061090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ayyar KK, Moss AC. Exosomes in Intestinal Inflammation. Front Pharmacol 2021;12:658505. [PMID: 34177577 DOI: 10.3389/fphar.2021.658505] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
95 Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA Mutation Confers Nicotinic Acid Auxotrophy in Pro-carcinogenic Intestinal Escherichia coli NC101. Front Microbiol 2021;12:670005. [PMID: 34149655 DOI: 10.3389/fmicb.2021.670005] [Reference Citation Analysis]
96 Ni H, Chen Y, Xia W, Wang C, Hu C, Sun L, Tang W, Cui H, Shen T, Liu Y, Li J. SATB2 defect promotes colitis and colitis-associated colorectal cancer by impairing Cl -/HCO3  - exchange and homeostasis of gut microbiota. J Crohns Colitis 2021:jjab094. [PMID: 34019628 DOI: 10.1093/ecco-jcc/jjab094] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Xia Y, Wang J, Fang X, Dou T, Han L, Yang C. Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease. J Appl Microbiol 2021. [PMID: 34008889 DOI: 10.1111/jam.15154] [Reference Citation Analysis]
98 Ding J, Ma X, Han L, Zhao X, Li A, Xin Q, Lian W, Li Z, Ren H, Ren Z. Gut microbial alterations in neonatal jaundice pre- and post-treatment. Biosci Rep 2021;41:BSR20210362. [PMID: 33860293 DOI: 10.1042/BSR20210362] [Reference Citation Analysis]
99 Guan D, Wang Z, Huo J, Xu S, Lam KP. Bruton's tyrosine kinase regulates gut immune homeostasis through attenuating Th1 response. Cell Death Dis 2021;12:431. [PMID: 33931590 DOI: 10.1038/s41419-021-03702-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Wang L, Yu M, Yang H. Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease. J Inflamm Res 2021;14:1701-16. [PMID: 33953597 DOI: 10.2147/JIR.S304101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Lucidi L, Pettorruso M, Vellante F, Di Carlo F, Ceci F, Santovito MC, Di Muzio I, Fornaro M, Ventriglio A, Tomasetti C, Valchera A, Gentile A, Kim YK, Martinotti G, Fraticelli S, Di Giannantonio M, De Berardis D. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment. Int J Mol Sci 2021;22:3723. [PMID: 33918462 DOI: 10.3390/ijms22073723] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
102 Ma Y, Liu G, Tang M, Fang J, Jiang H. Epigallocatechin Gallate Can Protect Mice From Acute Stress Induced by LPS While Stabilizing Gut Microbes and Serum Metabolites Levels. Front Immunol 2021;12:640305. [PMID: 33868268 DOI: 10.3389/fimmu.2021.640305] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
103 Kitabatake M, Matsumura Y, Ouji-Sageshima N, Nishioka T, Hara A, Kayano SI, Ito T. Persimmon-derived tannin ameliorates the pathogenesis of ulcerative colitis in a murine model through inhibition of the inflammatory response and alteration of microbiota. Sci Rep 2021;11:7286. [PMID: 33790314 DOI: 10.1038/s41598-021-86608-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
104 Wrage M, Kaltwasser J, Menge S, Mattner J. CD101 as an indicator molecule for pathological changes at the interface of host-microbiota interactions. Int J Med Microbiol 2021;311:151497. [PMID: 33773220 DOI: 10.1016/j.ijmm.2021.151497] [Reference Citation Analysis]
105 Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 2021;9:697. [PMID: 33801755 DOI: 10.3390/microorganisms9040697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
106 Memon A, Kim BY, Kim SE, Pyao Y, Lee YG, Kang SC, Lee WK. Anti-Inflammatory Effect of Phytoncide in an Animal Model of Gastrointestinal Inflammation. Molecules 2021;26:1895. [PMID: 33810618 DOI: 10.3390/molecules26071895] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
107 Kim KU, Kim J, Kim WH, Min H, Choi CH. Treatments of inflammatory bowel disease toward personalized medicine. Arch Pharm Res 2021;44:293-309. [PMID: 33763844 DOI: 10.1007/s12272-021-01318-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Wenderlein J, Böswald LF, Ulrich S, Kienzle E, Neuhaus K, Lagkouvardos I, Zenner C, Straubinger RK. Processing Matters in Nutrient-Matched Laboratory Diets for Mice-Microbiome. Animals (Basel) 2021;11:862. [PMID: 33803597 DOI: 10.3390/ani11030862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Weng YJ, Jiang DX, Liang J, Ye SC, Tan WK, Yu CY, Zhou Y. Effects of Pretreatment with Bifidobacterium bifidum Using 16S Ribosomal RNA Gene Sequencing in a Mouse Model of Acute Colitis Induced by Dextran Sulfate Sodium. Med Sci Monit 2021;27:e928478. [PMID: 33686049 DOI: 10.12659/MSM.928478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Chen DL, Dai YC, Zheng L, Chen YL, Zhang YL, Tang ZP. Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study. Medicine (Baltimore) 2021;100:e24845. [PMID: 33607855 DOI: 10.1097/MD.0000000000024845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Andersen-Civil AIS, Arora P, Williams AR. Regulation of Enteric Infection and Immunity by Dietary Proanthocyanidins. Front Immunol 2021;12:637603. [PMID: 33717185 DOI: 10.3389/fimmu.2021.637603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
112 Overstreet AC, Ramer-Tait AE, Suchodolski JS, Hostetter JM, Wang C, Jergens AE, Phillips GJ, Wannemuehler MJ. Temporal Dynamics of Chronic Inflammation on the Cecal Microbiota in IL-10-/- Mice. Front Immunol 2020;11:585431. [PMID: 33664728 DOI: 10.3389/fimmu.2020.585431] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
113 Baier J, Gänsbauer M, Giessler C, Arnold H, Muske M, Schleicher U, Lukassen S, Ekici A, Rauh M, Daniel C, Hartmann A, Schmid B, Tripal P, Dettmer K, Oefner PJ, Atreya R, Wirtz S, Bogdan C, Mattner J. Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J Clin Invest 2020;130:5703-20. [PMID: 32721946 DOI: 10.1172/JCI126923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
114 Chauhan A, Apostolov R, van Langenberg D, Garg M. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement. Intern Med J 2021;51:106-10. [PMID: 33572016 DOI: 10.1111/imj.15162] [Reference Citation Analysis]
115 Zhang W, Zou G, Li B, Du X, Sun Z, Sun Y, Jiang X. Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation. J Microbiol Biotechnol 2020;30:1132-41. [PMID: 32423189 DOI: 10.4014/jmb.2002.02044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
116 Kang S, Song Y, Jeon Y, Kim D, Park J, Soh J, Lee J, Kitalong C, Kim W, An H, Chang J, Lee J, Jin J. Comparative Study of Anti-Inflammatory Effect on DSS-Induced Ulcerative Colitis Between Novel Glycyrrhiza Variety and Official Compendia. Applied Sciences 2021;11:1545. [DOI: 10.3390/app11041545] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
117 Jaiswal P, Sharma S, Pratap A, Ansari M, Shukla VK, Basu S, Banerjee T. Significant presence of biofilm-producing gut-derived bacteria in anal fistula of chronic duration. Int Wound J 2021;18:519-24. [PMID: 33544431 DOI: 10.1111/iwj.13551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Wei X, Mei C, Li X, Xie Y. The Unique Microbiome and Immunity in Pancreatic Cancer. Pancreas 2021;50:119-29. [DOI: 10.1097/mpa.0000000000001744] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
119 Morgan NN, Mannon PJ. Flagellin-Specific CD4 Cytokine Production in Crohn Disease and Controls Is Limited to a Small Subset of Antigen-Induced CD40L+ T Cells. J Immunol 2021;206:345-54. [PMID: 33298614 DOI: 10.4049/jimmunol.2000918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Soopramanien M, Khan NA, Siddiqui R. Gut microbiota of animals living in polluted environments are a potential resource of anticancer molecules. J Appl Microbiol 2021;131:1039-55. [PMID: 33368930 DOI: 10.1111/jam.14981] [Reference Citation Analysis]
121 Toychiev A, Navruzov B, Pazylova D, Davis N, Badalova N, Osipova S. Intestinal protozoa and helminths in ulcerative colitis and the influence of anti-parasitic therapy on the course of the disease. Acta Trop 2021;213:105755. [PMID: 33188747 DOI: 10.1016/j.actatropica.2020.105755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Weinstein N, Garten B, Vainer J, Minaya D, Czaja K. Managing the Microbiome: How the Gut Influences Development and Disease. Nutrients 2020;13:E74. [PMID: 33383647 DOI: 10.3390/nu13010074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
123 Kakinuma Y. Significance of vagus nerve function in terms of pathogenesis of psychosocial disorders. Neurochem Int 2021;143:104934. [PMID: 33307153 DOI: 10.1016/j.neuint.2020.104934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Guerre P. Mycotoxin and Gut Microbiota Interactions. Toxins (Basel) 2020;12:E769. [PMID: 33291716 DOI: 10.3390/toxins12120769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
125 Rosca AE, Iesanu MI, Zahiu CDM, Voiculescu SE, Paslaru AC, Zagrean AM. Capsaicin and Gut Microbiota in Health and Disease. Molecules 2020;25:E5681. [PMID: 33276488 DOI: 10.3390/molecules25235681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
126 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Zubeldia-Varela E, Barber D, Barbas C, Perez-Gordo M, Rojo D. Sample pre-treatment procedures for the omics analysis of human gut microbiota: Turning points, tips and tricks for gene sequencing and metabolomics. J Pharm Biomed Anal 2020;191:113592. [PMID: 32947167 DOI: 10.1016/j.jpba.2020.113592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Gierse LC, Meene A, Schultz D, Schwaiger T, Karte C, Schröder C, Wang H, Wünsche C, Methling K, Kreikemeyer B, Fuchs S, Bernhardt J, Becher D, Lalk M, KoInfekt Study Group, Urich T, Riedel K. A Multi-Omics Protocol for Swine Feces to Elucidate Longitudinal Dynamics in Microbiome Structure and Function. Microorganisms 2020;8:E1887. [PMID: 33260576 DOI: 10.3390/microorganisms8121887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
129 Liao ZQ, Ji QF, Zhou BJ. Strategies for inflammatory bowel disease drug research by targeting gut microbiota. Shijie Huaren Xiaohua Zazhi 2020; 28(22): 1112-1120 [DOI: 10.11569/wcjd.v28.i22.1112] [Reference Citation Analysis]
130 Fu YS, Chu QS, Ashuro AA, Di DS, Zhang Q, Liu XM, Fan YG. The Effect of Probiotics, Prebiotics, and Synbiotics on CD4 Counts in HIV-Infected Patients: A Systematic Review and Meta-Analysis. Biomed Res Int 2020;2020:7947342. [PMID: 33294453 DOI: 10.1155/2020/7947342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
131 Yan ZX, Liu YM, Ma T, Xu MJ, Zhang XB, Zha XJ, Yang JH, Jiang P, Chen X, Lin ZW, Wu YH, Zu RZ, Lin WR, Lin XY. Efficacy and safety of retention enema with traditional Chinese medicine for ulcerative colitis: A meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2021;42:101278. [PMID: 33276227 DOI: 10.1016/j.ctcp.2020.101278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Niu W, Chen X, Xu R, Dong H, Yang F, Wang Y, Zhang Z, Ju J. Polysaccharides from natural resources exhibit great potential in the treatment of ulcerative colitis: A review. Carbohydr Polym 2021;254:117189. [PMID: 33357839 DOI: 10.1016/j.carbpol.2020.117189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
133 Diederen K, Li JV, Donachie GE, de Meij TG, de Waart DR, Hakvoort TBM, Kindermann A, Wagner J, Auyeung V, Te Velde AA, Heinsbroek SEM, Benninga MA, Kinross J, Walker AW, de Jonge WJ, Seppen J. Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease. Sci Rep 2020;10:18879. [PMID: 33144591 DOI: 10.1038/s41598-020-75306-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
134 Ishikawa T, Omori T, Kikuchi K. Bacterial biomechanics-From individual behaviors to biofilm and the gut flora. APL Bioeng 2020;4:041504. [PMID: 33163845 DOI: 10.1063/5.0026953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
135 Geng T, Su S, Sun K, Zhao L, Zhao Y, Bao N, Pan L, Sun H. Effects of feeding a Lactobacillus plantarum JL01 diet on caecal bacteria and metabolites of weaned piglets. Lett Appl Microbiol 2021;72:24-35. [PMID: 32989746 DOI: 10.1111/lam.13399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Yu P, Ke C, Guo J, Zhang X, Li B. Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis. Front Immunol 2020;11:575173. [PMID: 33123156 DOI: 10.3389/fimmu.2020.575173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
137 Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh) 2020;7:2001936. [PMID: 33101877 DOI: 10.1002/advs.202001936] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
138 Pereira NS, Queiroga TBD, da Silva DD, Nascimento MSL, Andrade CM, Souto JT, Ricci MF, Arantes RME, Zamboni DS, Chiari E, Câmara ACJD, Galvão LMDC, Guedes PMM. NOD2 receptor is crucial for protecting against the digestive form of Chagas disease. PLoS Negl Trop Dis 2020;14:e0008667. [PMID: 32986710 DOI: 10.1371/journal.pntd.0008667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
139 Kim B, Cho EJ, Yoon JH, Kim SS, Cheong JY, Cho SW, Park T. Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients. Cancers (Basel) 2020;12:E2705. [PMID: 32967314 DOI: 10.3390/cancers12092705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
140 Li S, Feng J, Wu F, Cai J, Zhang X, Wang H, Fetahu IS, Iwanicki I, Ma D, Hu T, Liu H, Wang B, Shi G, Tan L, Shi YG. TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8+ T-cell numbers. EMBO Rep 2020;21:e49425. [PMID: 32929842 DOI: 10.15252/embr.201949425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
141 Farid A, Hesham M, El-Dewak M, Amin A. The hidden hazardous effects of stevia and sucralose consumption in male and female albino mice in comparison to sucrose. Saudi Pharm J 2020;28:1290-300. [PMID: 33132722 DOI: 10.1016/j.jsps.2020.08.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
142 Bilski J, Wojcik D, Danielak A, Mazur-bialy A, Magierowski M, Tønnesen K, Brzozowski B, Surmiak M, Magierowska K, Pajdo R, Ptak-belowska A, Brzozowski T. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products. CPD 2020;26:2936-50. [DOI: 10.2174/1381612826666200427090127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Maltz RM, Keirsey J, Kim SC, Mackos AR, Gharaibeh RZ, Moore CC, Xu J, Somogyi A, Bailey MT. Social Stress Affects Colonic Inflammation, the Gut Microbiome, and Short-chain Fatty Acid Levels and Receptors. J Pediatr Gastroenterol Nutr 2019;68:533-40. [PMID: 30540706 DOI: 10.1097/MPG.0000000000002226] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 9.5] [Reference Citation Analysis]
144 Cui J, Wu F, Yang X, Liu T, Xia X, Chang X, Wang H, Sun L, Wei Y, Jia Z, Liu S, Han S, Chen B. Effect of gaseous hydrogen sulphide on growth performance and cecal microbial diversity of weaning pigs. Vet Med Sci 2021;7:424-31. [PMID: 32729230 DOI: 10.1002/vms3.324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease. J Allergy Clin Immunol. 2020;145:16-27. [PMID: 31910984 DOI: 10.1016/j.jaci.2019.11.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 169] [Article Influence: 36.5] [Reference Citation Analysis]
146 Yue YY, Fan XY, Zhang Q, Lu YP, Wu S, Wang S, Yu M, Cui CW, Sun ZR. Bibliometric analysis of subject trends and knowledge structures of gut microbiota. World J Clin Cases 2020; 8(13): 2817-2832 [PMID: 32742991 DOI: 10.12998/wjcc.v8.i13.2817] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
147 Zittan E, Gralnek IM, Berns MS. The New Proactive Approach and Precision Medicine in Crohn's Disease. Biomedicines 2020;8:E193. [PMID: 32635316 DOI: 10.3390/biomedicines8070193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
148 Wei X, Zhang L, Zhang R, Koci M, Si D, Ahmad B, Cheng J, Wang J, Aihemaiti M, Zhang M. A Novel Cecropin-LL37 Hybrid Peptide Protects Mice Against EHEC Infection-Mediated Changes in Gut Microbiota, Intestinal Inflammation, and Impairment of Mucosal Barrier Functions. Front Immunol 2020;11:1361. [PMID: 32695115 DOI: 10.3389/fimmu.2020.01361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
149 Berg DR, Colombel JF, Ungaro R. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1896-905. [PMID: 30934053 DOI: 10.1093/ibd/izz059] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
150 Costa RFA, Ferrari MLA, Bringer MA, Darfeuille-Michaud A, Martins FS, Barnich N. Characterization of mucosa-associated Escherichia coli strains isolated from Crohn's disease patients in Brazil. BMC Microbiol 2020;20:178. [PMID: 32576138 DOI: 10.1186/s12866-020-01856-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
151 Míguez B, Vila C, Venema K, Parajó JC, Alonso JL. Potential of High- and Low-Acetylated Galactoglucomannooligosaccharides as Modulators of the Microbiota Composition and Their Activity: A Comparison Using the In Vitro Model of the Human Colon TIM-2. J Agric Food Chem 2020;68:7617-29. [DOI: 10.1021/acs.jafc.0c02225] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
152 Thomann AK, Mak JWY, Zhang JW, Wuestenberg T, Ebert MP, Sung JJY, Bernstein ÇN, Reindl W, Ng SC. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:247-66. [PMID: 32525605 DOI: 10.1111/apt.15787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
153 Ikarashi N, Fujitate N, Togashi T, Takayama N, Fukuda N, Kon R, Sakai H, Kamei J, Sugiyama K. Acacia Polyphenol Ameliorates Atopic Dermatitis in Trimellitic Anhydride-Induced Model Mice via Changes in the Gut Microbiota. Foods 2020;9:E773. [PMID: 32545274 DOI: 10.3390/foods9060773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Park SK, Kim HN, Choi CH, Im JP, Cha JM, Eun CS, Kim TO, Kang SB, Bang KB, Kim HG, Jung Y, Yoon H, Han DS, Lee CW, Ahn K, Kim HL, Park DI. Differentially Abundant Bacterial Taxa Associated with Prognostic Variables of Crohn's Disease: Results from the IMPACT Study. J Clin Med 2020;9:E1748. [PMID: 32516912 DOI: 10.3390/jcm9061748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
155 Kwak MS, Cha JM, Shin HP, Jeon JW, Yoon JY. Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease. Front Microbiol 2020;11:1162. [PMID: 32582102 DOI: 10.3389/fmicb.2020.01162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
156 Hu Y, Fang L, Nicholson C, Wang K. Implications of Error-Prone Long-Read Whole-Genome Shotgun Sequencing on Characterizing Reference Microbiomes. iScience 2020;23:101223. [PMID: 32563152 DOI: 10.1016/j.isci.2020.101223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
157 Khorshidi M, Djafarian K, Aghayei E, Shab-bidar S. A posteriori dietary patterns and risk of inflammatory bowel disease: a meta-analysis of observational studies. International Journal for Vitamin and Nutrition Research 2020;90:376-84. [DOI: 10.1024/0300-9831/a000508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
158 Kitamoto S, Nagao-Kitamoto H, Hein R, Schmidt TM, Kamada N. The Bacterial Connection between the Oral Cavity and the Gut Diseases. J Dent Res 2020;99:1021-9. [PMID: 32464078 DOI: 10.1177/0022034520924633] [Cited by in Crossref: 21] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
159 Islam M, Chen B, Spraggins JM, Kelly RT, Lau KS. Use of Single-Cell -Omic Technologies to Study the Gastrointestinal Tract and Diseases, From Single Cell Identities to Patient Features. Gastroenterology 2020;159:453-466.e1. [PMID: 32417404 DOI: 10.1053/j.gastro.2020.04.073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
160 Tang LL, Feng WZ, Cheng JJ, Gong YN. Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis. Int J Colorectal Dis 2020;35:1025-34. [PMID: 32388604 DOI: 10.1007/s00384-020-03599-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
161 Chen D, Chen G, Chen C, Zeng X, Ye H. Prebiotics effects in vitro of polysaccharides from tea flowers on gut microbiota of healthy persons and patients with inflammatory bowel disease. Int J Biol Macromol 2020;158:968-76. [PMID: 32371134 DOI: 10.1016/j.ijbiomac.2020.04.248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
162 Bian X, Yang L, Wu W, Lv L, Jiang X, Wang Q, Wu J, Li Y, Ye J, Fang D, Shi D, Wang K, Wang Q, Lu Y, Xie J, Xia J, Li L. Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Microb Biotechnol 2020;13:1228-44. [PMID: 32363766 DOI: 10.1111/1751-7915.13583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
163 Silva NOE, de Brito BB, da Silva FAF, Santos MLC, de Melo FF. Probiotics in inflammatory bowel disease: Does it work? World J Meta-Anal 2020; 8(2): 54-66 [DOI: 10.13105/wjma.v8.i2.54] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
164 Hua S. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol 2020;11:524. [PMID: 32425781 DOI: 10.3389/fphar.2020.00524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 69] [Article Influence: 10.5] [Reference Citation Analysis]
165 Fenton CG, Taman H, Florholmen J, Sørbye SW, Paulssen RH. Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflamm Bowel Dis 2021;27:94-105. [PMID: 32322884 DOI: 10.1093/ibd/izaa075] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
166 Liu R, Zhang Y, Gao J, Li X. Effects of octylphenol exposure on the lipid metabolism and microbiome of the intestinal tract of Rana chensinensis tadpole by RNAseq and 16s amplicon sequencing. Ecotoxicol Environ Saf 2020;197:110650. [PMID: 32315788 DOI: 10.1016/j.ecoenv.2020.110650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
167 Abu-Ghazaleh N, Chua WJ, Gopalan V. Intestinal microbiota and its association with colon cancer and red/processed meat consumption. J Gastroenterol Hepatol 2021;36:75-88. [PMID: 32198788 DOI: 10.1111/jgh.15042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
168 Song G, Fiocchi C, Achkar JP. Acupuncture in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1129-39. [PMID: 30535303 DOI: 10.1093/ibd/izy371] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
169 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 73] [Article Influence: 16.0] [Reference Citation Analysis]
170 Saeedi BJ, Liu KH, Owens JA, Hunter-Chang S, Camacho MC, Eboka RU, Chandrasekharan B, Baker NF, Darby TM, Robinson BS, Jones RM, Jones DP, Neish AS. Gut-Resident Lactobacilli Activate Hepatic Nrf2 and Protect Against Oxidative Liver Injury. Cell Metab 2020;31:956-968.e5. [PMID: 32213347 DOI: 10.1016/j.cmet.2020.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 55] [Article Influence: 11.5] [Reference Citation Analysis]
171 Menchetti L, Curone G, Filipescu IE, Barbato O, Leonardi L, Guelfi G, Traina G, Casagrande-Proietti P, Riva F, Casano AB, Piro F, Vigo D, Quattrone A, Brecchia G. The Prophylactic Use of Bovine Colostrum in a Murine Model of TNBS-Induced Colitis. Animals (Basel) 2020;10:E492. [PMID: 32183497 DOI: 10.3390/ani10030492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
172 Šašala M, Majorová E, Vrzgula A, Fandáková I. Evaluation of Invasive Intra-abdominal Candidiasis in Crohn Disease at the Time of Surgery. Ann Coloproctol 2020;36:12-6. [PMID: 32146783 DOI: 10.3393/ac.2018.10.15.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
173 Lopetuso LR, Ianiro G, Allegretti JR, Bibbò S, Gasbarrini A, Scaldaferri F, Cammarota G. Fecal transplantation for ulcerative colitis: current evidence and future applications. Expert Opin Biol Ther 2020;20:343-51. [PMID: 32083498 DOI: 10.1080/14712598.2020.1733964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
174 Chaubey P, Momin M, Sawarkar S. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Front Pharmacol 2019;10:1628. [PMID: 32161536 DOI: 10.3389/fphar.2019.01628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
175 Godny L, Maharshak N, Reshef L, Goren I, Yahav L, Fliss-Isakov N, Gophna U, Tulchinsky H, Dotan I. Fruit Consumption is Associated with Alterations in Microbial Composition and Lower Rates of Pouchitis. J Crohns Colitis 2019;13:1265-72. [PMID: 30828722 DOI: 10.1093/ecco-jcc/jjz053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]
176 Oh WS, Jung JC, Choi YM, Mun JY, Ku SK, Song CH. Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. Food Sci Nutr 2020;8:1718-28. [PMID: 32180979 DOI: 10.1002/fsn3.1460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
177 Shin JH, Lee YK, Shon WJ, Kim B, Jeon CO, Cho JY, Morse HC 3rd, Choi EY, Shin DM. Gut microorganisms and their metabolites modulate the severity of acute colitis in a tryptophan metabolism-dependent manner. Eur J Nutr. 2020;59:3591-3601. [PMID: 32055962 DOI: 10.1007/s00394-020-02194-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
178 Kim SW, Kim S, Son M, Cheon JH, Park YS. Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling. Sci Rep 2020;10:2232. [PMID: 32042047 DOI: 10.1038/s41598-020-59314-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
179 Ilie OD, Ciobica A, McKenna J, Doroftei B, Mavroudis I. Minireview on the Relations between Gut Microflora and Parkinson's Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities. Oxid Med Cell Longev 2020;2020:4518023. [PMID: 32089768 DOI: 10.1155/2020/4518023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
180 Chang X, Wang SL, Zhao SB, Shi YH, Pan P, Gu L, Yao J, Li ZS, Bai Y. Extracellular Vesicles with Possible Roles in Gut Intestinal Tract Homeostasis and IBD. Mediators Inflamm 2020;2020:1945832. [PMID: 32410847 DOI: 10.1155/2020/1945832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 7.5] [Reference Citation Analysis]
181 Tanaka A, Kanmura S, Morinaga Y, Kawabata K, Arima S, Sasaki F, Nasu Y, Tanoue S, Hashimoto S, Takeshita M, Takeda S, Ido A. Oral administration of Lactobacillus plantarum 06CC2 prevents experimental colitis in mice via an anti‑inflammatory response. Mol Med Rep 2020;21:1181-91. [PMID: 31922249 DOI: 10.3892/mmr.2020.10925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
182 Kim DH, Kim S, Ahn JB, Kim JH, Ma HW, Seo DH, Che X, Park KC, Jeon JY, Kim SY, Lee HC, Lee JY, Kim TI, Kim WH, Kim SW, Cheon JH. Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice. Int J Med Microbiol. 2020;310:151391. [PMID: 32007342 DOI: 10.1016/j.ijmm.2020.151391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
183 Schirbel A, Rebert N, Sadler T, West G, Rieder F, Wagener C, Horst A, Sturm A, de la Motte C, Fiocchi C. Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy. Inflamm Bowel Dis 2019;25:294-305. [PMID: 30295747 DOI: 10.1093/ibd/izy316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
184 Kanwal S, Joseph TP, Aliya S, Song S, Saleem MZ, Nisar MA, Wang Y, Meyiah A, Ma Y, Xin Y. Attenuation of DSS induced colitis by Dictyophora indusiata polysaccharide (DIP) via modulation of gut microbiota and inflammatory related signaling pathways. Journal of Functional Foods 2020;64:103641. [DOI: 10.1016/j.jff.2019.103641] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 10.5] [Reference Citation Analysis]
185 Abdelhalim KA, Uzel A, Ünal NG. The role of major virulence factors and pathogenicity of adherent-invasive Escherichia coli in patients with Crohn's disease. Prz Gastroenterol 2020;15:279-88. [PMID: 33777266 DOI: 10.5114/pg.2020.93235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
186 Aranda-olmedo I, Rubio LA. Dietary legumes, intestinal microbiota, inflammation and colorectal cancer. Journal of Functional Foods 2020;64:103707. [DOI: 10.1016/j.jff.2019.103707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
187 Moffa S, Mezza T, Cefalo CMA, Cinti F, Impronta F, Sorice GP, Santoro A, Di Giuseppe G, Pontecorvi A, Giaccari A. The Interplay between Immune System and Microbiota in Diabetes. Mediators Inflamm 2019;2019:9367404. [PMID: 32082078 DOI: 10.1155/2019/9367404] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
188 Wang HW, Miao CY, Liu J, Zhang Y, Zhu SQ, Zhou BH. Fluoride-induced rectal barrier damage and microflora disorder in mice. Environ Sci Pollut Res Int 2020;27:7596-607. [PMID: 31885060 DOI: 10.1007/s11356-019-07201-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
189 Siebert JC, Görg C, Palmer B, Lozupone C. Visualizing microbiome-immune system interplay. Immunotherapy 2019;11:63-7. [PMID: 30730269 DOI: 10.2217/imt-2018-0138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
190 Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis 2020;136:104714. [PMID: 31846737 DOI: 10.1016/j.nbd.2019.104714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
191 Mischel RA, Muchhala KH, Dewey WL, Akbarali HI. The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance. J Pain 2020;21:751-62. [PMID: 31841668 DOI: 10.1016/j.jpain.2019.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
192 Godny L, Reshef L, Pfeffer-Gik T, Goren I, Yanai H, Tulchinsky H, Gophna U, Dotan I. Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. Eur J Nutr 2020;59:3183-90. [PMID: 31813010 DOI: 10.1007/s00394-019-02158-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
193 Jiang H, Li J, Zhang B, Huang R, Zhang J, Chen Z, Shang X, Li X, Nie X. Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma. Front Oncol 2019;9:1346. [PMID: 31867274 DOI: 10.3389/fonc.2019.01346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
194 Lucafò M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, Decorti G. Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients. Clin Transl Sci 2020;13:238-59. [PMID: 31675176 DOI: 10.1111/cts.12722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
195 Hu L, Jin L, Xia D, Zhang Q, Ma L, Zheng H, Xu T, Chang S, Li X, Xun Z, Xu Y, Zhang C, Chen F, Wang S. Nitrate ameliorates dextran sodium sulfate-induced colitis by regulating the homeostasis of the intestinal microbiota. Free Radic Biol Med 2020;152:609-21. [PMID: 31811920 DOI: 10.1016/j.freeradbiomed.2019.12.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
196 Aggeletopoulou I, Konstantakis C, Assimakopoulos SF, Triantos C. The role of the gut microbiota in the treatment of inflammatory bowel diseases. Microb Pathog 2019;137:103774. [PMID: 31586663 DOI: 10.1016/j.micpath.2019.103774] [Cited by in Crossref: 26] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
197 Ahn SI, Cho S, Choi NJ. Effect of dietary probiotics on colon length in an inflammatory bowel disease-induced murine model: A meta-analysis. J Dairy Sci. 2020;103:1807-1819. [PMID: 31785874 DOI: 10.3168/jds.2019-17356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
198 Li A, Ni W, Zhang Q, Li Y, Zhang X, Wu H, Du P, Hou J, Zhang Y. Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate‐induced colitis. Microbiol Immunol 2019;64:23-32. [DOI: 10.1111/1348-0421.12749] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
199 Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease. Front Immunol. 2019;10:2754. [PMID: 31824517 DOI: 10.3389/fimmu.2019.02754] [Cited by in Crossref: 27] [Cited by in F6Publishing: 65] [Article Influence: 9.0] [Reference Citation Analysis]
200 Takakuwa A, Nakamura K, Kikuchi M, Sugimoto R, Ohira S, Yokoi Y, Ayabe T. Butyric Acid and Leucine Induce α-Defensin Secretion from Small Intestinal Paneth Cells. Nutrients 2019;11:E2817. [PMID: 31752111 DOI: 10.3390/nu11112817] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
201 Chen Y, Wang Y, Shen J. Role of environmental factors in the pathogenesis of Crohn’s disease: a critical review. Int J Colorectal Dis 2019;34:2023-34. [DOI: 10.1007/s00384-019-03441-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
202 Bertoni S, Machness A, Tiboni M, Bártolo R, Santos HA. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting. Biopolymers 2020;111:e23336. [PMID: 31724750 DOI: 10.1002/bip.23336] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
203 Quraishi MNN, Yalchin M, Blackwell C, Segal J, Sharma N, Hawkey P, McCune V, Hart AL, Gaya D, Ives NJ, Magill L, Loi S, Hewitt C, Gerasimidis K, Loman NJ, Hansen R, McMullan C, Mathers J, Quince C, Crees N, Iqbal T. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. BMJ Open 2019;9:e030659. [PMID: 31719078 DOI: 10.1136/bmjopen-2019-030659] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
204 Yoon JY. Nutritional approach as therapeutic manipulation in inflammatory bowel disease. Intest Res 2019;17:463-75. [PMID: 31665832 DOI: 10.5217/ir.2019.00078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
205 Scarpato E, Russo M, Staiano A. Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases. J Clin Gastroenterol 2018;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S7-9. [PMID: 30036240 DOI: 10.1097/MCG.0000000000001095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
206 Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease. Am J Physiol Gastrointest Liver Physiol 2020;318:G84-98. [PMID: 31657225 DOI: 10.1152/ajpgi.00118.2019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 11.7] [Reference Citation Analysis]
207 Hua S. Physiological and Pharmaceutical Considerations for Rectal Drug Formulations. Front Pharmacol 2019;10:1196. [PMID: 31680970 DOI: 10.3389/fphar.2019.01196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
208 Nopvichai C, Pongkorpsakol P, Wongkrasant P, Wangpaiboon K, Charoenwongpaiboon T, Ito K, Muanprasat C, Pichyangkura R. Galactomannan Pentasaccharide Produced from Copra Meal Enhances Tight Junction Integration of Epithelial Tissue through Activation of AMPK. Biomedicines 2019;7:E81. [PMID: 31614968 DOI: 10.3390/biomedicines7040081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
209 Stange EF, Schroeder BO. Microbiota and mucosal defense in IBD: an update. Expert Rev Gastroenterol Hepatol. 2019;13:963-976. [PMID: 31603356 DOI: 10.1080/17474124.2019.1671822] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
210 Yang P, Hu H, Li Y, Ai Q, Zhang W, Zhang Y, Mai K. Effect of dietary xylan on immune response, tight junction protein expression and bacterial community in the intestine of juvenile turbot (Scophthalmus maximus L.). Aquaculture 2019;512:734361. [DOI: 10.1016/j.aquaculture.2019.734361] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
211 Giudici F, Lombardelli L, Russo E, Cavalli T, Zambonin D, Logiodice F, Kullolli O, Giusti L, Bargellini T, Fazi M, Biancone L, Scaringi S, Clemente AM, Perissi E, Delfino G, Torcia MG, Ficari F, Tonelli F, Piccinni MP, Malentacchi C. Multiplex gene expression profile in inflamed mucosa of patients with Crohn’s disease ileal localization: A pilot study. World J Clin Cases 2019; 7(17): 2463-2476 [PMID: 31559282 DOI: 10.12998/wjcc.v7.i17.2463] [Reference Citation Analysis]
212 Han MM, Zhu XY, Peng YF, Lin H, Liu DC, Li L. The alterations of gut microbiota in mice with chronic pancreatitis. Ann Transl Med 2019;7:464. [PMID: 31700900 DOI: 10.21037/atm.2019.08.18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
213 Goto Y. Epithelial Cells as a Transmitter of Signals From Commensal Bacteria and Host Immune Cells. Front Immunol 2019;10:2057. [PMID: 31555282 DOI: 10.3389/fimmu.2019.02057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
214 Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van Der Woude CJ, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. Journal of Crohn's and Colitis 2020;14:309-15. [DOI: 10.1093/ecco-jcc/jjz148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
215 Siebert JC, Neff CP, Schneider JM, Regner EH, Ohri N, Kuhn KA, Palmer BE, Lozupone CA, Görg C. VOLARE: visual analysis of disease-associated microbiome-immune system interplay. BMC Bioinformatics 2019;20:432. [PMID: 31429723 DOI: 10.1186/s12859-019-3021-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
216 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 127] [Cited by in F6Publishing: 201] [Article Influence: 42.3] [Reference Citation Analysis]
217 Brun P. The profiles of dysbiotic microbial communities. AIMS Microbiol 2019;5:87-101. [PMID: 31384705 DOI: 10.3934/microbiol.2019.1.87] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
218 Borren NZ, van der Woude CJ, Ananthakrishnan AN. Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol. 2019;16:247-259. [PMID: 30531816 DOI: 10.1038/s41575-018-0091-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 26.3] [Reference Citation Analysis]
219 Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, Vega MCG, Govillard L, Tackett MR, Tejada G, Gónzalez E, Anguita J, Bujanda L, Orcasitas AMC, Aransay AM, Maíz O, López de Munain A, Falcón-Pérez JM. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.EBioMedicine. 2019;46:499-511. [PMID: 31327695 DOI: 10.1016/j.ebiom.2019.07.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
220 Coufal S, Galanova N, Bajer L, Gajdarova Z, Schierova D, Jiraskova Zakostelska Z, Kostovcikova K, Jackova Z, Stehlikova Z, Drastich P, Tlaskalova-Hogenova H, Kverka M. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response. Cells 2019;8:E719. [PMID: 31337064 DOI: 10.3390/cells8070719] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
221 Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity 2019;50:212-224.e4. [PMID: 30650377 DOI: 10.1016/j.immuni.2018.12.015] [Cited by in Crossref: 132] [Cited by in F6Publishing: 184] [Article Influence: 44.0] [Reference Citation Analysis]
222 Gutin L, Piceno Y, Fadrosh D, Lynch K, Zydek M, Kassam Z, Lamere B, Terdiman J, Ma A, Somsouk M, Lynch S, El-nachef N. Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile. United European Gastroenterol j 2019;7:807-14. [DOI: 10.1177/2050640619845986] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 12.7] [Reference Citation Analysis]
223 Turpin W, Goethel A, Bedrani L, Croitoru Mdcm K. Determinants of IBD Heritability: Genes, Bugs, and More. Inflamm Bowel Dis 2018;24:1133-48. [PMID: 29701818 DOI: 10.1093/ibd/izy085] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 21.7] [Reference Citation Analysis]
224 Lengfelder I, Sava IG, Hansen JJ, Kleigrewe K, Herzog J, Neuhaus K, Hofmann T, Sartor RB, Haller D. Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis. Front Immunol 2019;10:1420. [PMID: 31281321 DOI: 10.3389/fimmu.2019.01420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
225 Nusbaum DJ, Sun F, Ren J, Zhu Z, Ramsy N, Pervolarakis N, Kunde S, England W, Gao B, Fiehn O, Michail S, Whiteson K. Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients. FEMS Microbiol Ecol 2018;94. [PMID: 30010747 DOI: 10.1093/femsec/fiy133] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
226 Boursi B, Werner TJ, Gholami S, Margalit O, Baruch E, Markel G, Eshet Y, Houshmand S, Shacham-shmueli E, Mitchell TC, Mamtani R, Alavi A, Yang Y. Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma. Melanoma Research 2019;29:318-21. [DOI: 10.1097/cmr.0000000000000566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
227 Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 2019;68:1014-23. [PMID: 30045880 DOI: 10.1136/gutjnl-2017-315084] [Cited by in Crossref: 234] [Cited by in F6Publishing: 235] [Article Influence: 78.0] [Reference Citation Analysis]
228 Chen X, Yang K, Xu Y, Li K. Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis. Medicine (Baltimore) 2019;98:e15718. [PMID: 31096525 DOI: 10.1097/MD.0000000000015718] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
229 Liu S, Si C, Yu Y, Zhao G, Chen L, Zhao Y, Zhang Z, Li H, Chen Y, Min L, Zhang S, Zhu S. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome. Front Cell Infect Microbiol 2019;9:178. [PMID: 31192167 DOI: 10.3389/fcimb.2019.00178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
230 Li Y, Liu M, Zhou J, Hou B, Su X, Liu Z, Yuan J, Li M. Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice. Beneficial Microbes 2019;10:543-53. [DOI: 10.3920/bm2018.0122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
231 He YS, Hui HY, Tan ZJ. Role of intestinal flora characteristics in traditional Chinese medicine-based diagnosis and treatment of spleen and stomach diseases. Shijie Huaren Xiaohua Zazhi 2019; 27(10): 605-610 [DOI: 10.11569/wcjd.v27.i10.605] [Reference Citation Analysis]
232 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
233 Lv J, Guo L, Liu JJ, Zhao HP, Zhang J, Wang JH. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol 2019; 25(18): 2149-2161 [PMID: 31143067 DOI: 10.3748/wjg.v25.i18.2149] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 29] [Article Influence: 13.3] [Reference Citation Analysis]
234 Nakamura Y, Nagai Y, Kobayashi T, Furukawa K, Oikawa Y, Shimada A, Tanaka Y. Characteristics of Gut Microbiota in Patients With Diabetes Determined by Data Mining Analysis of Terminal Restriction Fragment Length Polymorphisms. J Clin Med Res 2019;11:401-6. [PMID: 31143306 DOI: 10.14740/jocmr3791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
235 Hoffman S, Aviv Cohen N, Carroll IM, Tulchinsky H, Borovok I, Dotan I, Maharshak N. Faecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier. Journal of Crohn's and Colitis 2019;13:1558-68. [DOI: 10.1093/ecco-jcc/jjz086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
236 Sun M, Du B, Shi Y, Lu Y, Zhou Y, Liu B. Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis. Med Sci Monit 2019;25:3303-15. [PMID: 31055592 DOI: 10.12659/MSM.916009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
237 Altomare A, Putignani L, Del Chierico F, Cocca S, Angeletti S, Ciccozzi M, Tripiciano C, Dalla Piccola B, Cicala M, Guarino MPL. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota. Digestive and Liver Disease 2019;51:648-56. [DOI: 10.1016/j.dld.2018.11.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
238 Yu W, Su X, Chen W, Tian X, Zhang K, Guo G, Zhou L, Zeng T, Han B. Three types of gut bacteria collaborating to improve Kui Jie’an enema treat DSS-induced colitis in mice. Biomedicine & Pharmacotherapy 2019;113:108751. [DOI: 10.1016/j.biopha.2019.108751] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
239 Bourgonje AR, von Martels JZH, Bulthuis MLC, van Londen M, Faber KN, Dijkstra G, van Goor H. Crohn's Disease in Clinical Remission Is Marked by Systemic Oxidative Stress. Front Physiol 2019;10:499. [PMID: 31080419 DOI: 10.3389/fphys.2019.00499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
240 Mechie NC, Mavropoulou E, Ellenrieder V, Petzold G, Kunsch S, Neesse A, Amanzada A. Serum vitamin D but not zinc levels are associated with different disease activity status in patients with inflammatory bowel disease. Medicine (Baltimore) 2019;98:e15172. [PMID: 30985701 DOI: 10.1097/MD.0000000000015172] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
241 Lam WC, Zhao C, Ma WJ, Yao L. The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis. Gastroenterol Res Pract 2019;2019:1287493. [PMID: 31178906 DOI: 10.1155/2019/1287493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
242 Fritsch J, Abreu MT. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg? Gastrointest Endosc Clin N Am 2019;29:381-93. [PMID: 31078242 DOI: 10.1016/j.giec.2019.02.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
243 Jang YJ, Kim WK, Han DH, Lee K, Ko G. Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota. Gut Microbes 2019;10:696-711. [PMID: 30939976 DOI: 10.1080/19490976.2019.1589281] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 22.3] [Reference Citation Analysis]
244 Roubalová R, Procházková P, Papežová H, Smitka K, Bilej M, Tlaskalová-Hogenová H. Anorexia nervosa: Gut microbiota-immune-brain interactions. Clin Nutr 2020;39:676-84. [PMID: 30952533 DOI: 10.1016/j.clnu.2019.03.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
245 Levy AN, Allegretti JR. Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819836893. [PMID: 30906424 DOI: 10.1177/1756284819836893] [Cited by in Crossref: 29] [Cited by in F6Publishing: 39] [Article Influence: 9.7] [Reference Citation Analysis]
246 Thomas KS, Owen KA, Conger K, Llewellyn RA, Bouton AH, Casanova JE. Non-redundant functions of FAK and Pyk2 in intestinal epithelial repair. Sci Rep 2019;9:4497. [PMID: 30872746 DOI: 10.1038/s41598-019-41116-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
247 Zhang B, Dong Y, Yu N, Sun Y, Xing Y, Yang F, Yu X, Sun W, Sun J, Li X, Xiu Z. Intestinal metabolism of baicalein after oral administration in mice: Pharmacokinetics and mechanisms. Journal of Functional Foods 2019;54:53-63. [DOI: 10.1016/j.jff.2018.12.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
248 Wang X, Xia J, Jiang C. Role of gut microbiota in the development of non-alcoholic fatty liver disease. Liver Research 2019;3:25-30. [DOI: 10.1016/j.livres.2019.01.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
249 Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019;558:201-14. [DOI: 10.1016/j.ijpharm.2018.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
250 Chae JM, Chang MH, Heo W, Cho HT, Lee DH, Hwang BB, Kim JW, Yoon SM, Yang S, Lee JH, Kim YJ. LB-9, Novel Probiotic Lactic Acid Bacteria, Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice by Inhibiting TNF- α -Mediated Apoptosis of Intestinal Epithelial Cells. Journal of Medicinal Food 2019;22:271-6. [DOI: 10.1089/jmf.2018.4236] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
251 Huang X, Fan X, Ying J, Chen S. Emerging trends and research foci in gastrointestinal microbiome. J Transl Med. 2019;17:67. [PMID: 30819194 DOI: 10.1186/s12967-019-1810-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
252 Langeneckert AE, Lunemann S, Martrus G, Salzberger W, Hess LU, Ziegler AE, Poch T, Ravichandran G, Matschl U, Bosse JB, Tiegs G, Fischer L, Koch M, Herkel J, Oldhafer KJ, Schramm C, Altfeld M. CCL21-expression and accumulation of CCR7+ NK cells in livers of patients with primary sclerosing cholangitis. Eur J Immunol 2019;49:758-69. [PMID: 30785638 DOI: 10.1002/eji.201847965] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
253 Zeng Y, Lin Y, Li L, Li Y, Zhang X, Wang M, Chen Y, Luo L, Lu B, Xie Z, Liao Q. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1110-1111:133-43. [PMID: 30807966 DOI: 10.1016/j.jchromb.2019.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
254 Shah SC, Khalili H, Chen CY, Ahn HS, Ng SC, Burisch J, Colombel JF. Sex-based differences in the incidence of inflammatory bowel diseases-pooled analysis of population-based studies from the Asia-Pacific region. Aliment Pharmacol Ther. 2019;49:904-911. [PMID: 30773656 DOI: 10.1111/apt.15178] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
255 Craven MD, Washabau RJ. Comparative pathophysiology and management of protein-losing enteropathy. J Vet Intern Med 2019;33:383-402. [PMID: 30762910 DOI: 10.1111/jvim.15406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
256 Dobranowski PA, Tang C, Sauvé JP, Menzies SC, Sly LM. Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice. Gut Microbes 2019;10:578-98. [PMID: 30760087 DOI: 10.1080/19490976.2018.1560767] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
257 Kelly CR, Ananthakrishnan AN. Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis. JAMA 2019;321:151-2. [PMID: 30644970 DOI: 10.1001/jama.2018.20397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
258 Townsend CM, Parker CE, MacDonald JK, Nguyen TM, Jairath V, Feagan BG, Khanna R. Antibiotics for induction and maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2019;2:CD012730. [PMID: 30731030 DOI: 10.1002/14651858.CD012730.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
259 Yao Q, Yang H, Wang X, Wang H. Effects of hexavalent chromium on intestinal histology and microbiota in Bufo gargarizans tadpoles. Chemosphere 2019;216:313-23. [DOI: 10.1016/j.chemosphere.2018.10.147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
260 Heidarian F, Alebouyeh M, Shahrokh S, Balaii H, Zali MR. Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction. Curr Res Transl Med 2019;67:41-50. [PMID: 30685379 DOI: 10.1016/j.retram.2019.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
261 Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, Michaud M, Lang JK, Gallini Comeau CA, Dreyfuss JM, Glickman JN, Vlamakis H, Ananthakrishnan A, Kostic A, Garrett WS, Xavier RJ. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. Elife. 2019;8:e39982. [PMID: 30666959 DOI: 10.7554/elife.39982] [Cited by in Crossref: 30] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
262 Chaparro M, Garre A, Ricart E, Iglesias-Flores E, Taxonera C, Domènech E, Gisbert JP; ENEIDA study group. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU. Aliment Pharmacol Ther 2019;49:419-28. [PMID: 30637837 DOI: 10.1111/apt.15114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
263 Malla MA, Dubey A, Kumar A, Yadav S, Hashem A, Abd Allah EF. Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment. Front Immunol. 2018;9:2868. [PMID: 30666248 DOI: 10.3389/fimmu.2018.02868] [Cited by in Crossref: 81] [Cited by in F6Publishing: 101] [Article Influence: 27.0] [Reference Citation Analysis]
264 Fu X, Liu Z, Zhu C, Mou H, Kong Q. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria.Crit Rev Food Sci Nutr. 2019;59:S130-S152. [PMID: 30580556 DOI: 10.1080/10408398.2018.1542587] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 16.8] [Reference Citation Analysis]
265 Zhang C, Zhang W, Zhang J, Jing Y, Yang M, Du L, Gao F, Gong H, Chen L, Li J, Liu H, Qin C, Jia Y, Qiao J, Wei B, Yu Y, Zhou H, Liu Z, Yang D, Li J. Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury. J Transl Med. 2018;16:353. [PMID: 30545398 DOI: 10.1186/s12967-018-1735-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
266 Schäffler H, Geiss D, Gittel N, Rohde S, Huth A, Glass Ä, Brandhorst G, Jaster R, Lamprecht G. Mutations in the NOD2 gene are associated with a specific phenotype and lower anti-tumor necrosis factor trough levels in Crohn's disease. J Dig Dis 2018;19:678-84. [PMID: 30284387 DOI: 10.1111/1751-2980.12677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
267 Eissa N, Kittana H, Gomes-Neto JC, Hussein H. Mucosal immunity and gut microbiota in dogs with chronic enteropathy. Res Vet Sci 2019;122:156-64. [PMID: 30504001 DOI: 10.1016/j.rvsc.2018.11.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
268 Garrido-estepa M, Latasa P, Ordóñez-león GY, Martínez-avilés M, de la Torre A, García-comas L. Non-Typhi, non-Paratyphi Salmonella-related hospitalisations in Spain: trends, clinical aspects, risk factors for worse prognosis and hospital costs. Eur J Clin Microbiol Infect Dis 2019;38:337-46. [DOI: 10.1007/s10096-018-3433-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
269 Figliuolo VR, Coutinho-Silva R, Coutinho CMLM. Contribution of sulfate-reducing bacteria to homeostasis disruption during intestinal inflammation. Life Sci 2018;215:145-51. [PMID: 30414430 DOI: 10.1016/j.lfs.2018.11.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
270 Bak A, Ashford M, Brayden DJ. Local delivery of macromolecules to treat diseases associated with the colon. Adv Drug Deliv Rev 2018;136-137:2-27. [PMID: 30359631 DOI: 10.1016/j.addr.2018.10.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
271 Shah SC, Faith J, Colombel J. Microbial-Host Interactions in Inflammatory Bowel Disease, Functional Bowel Disease, Obesity and Obesity-Related Metabolic Disease. Gastroenterology 2018;155:1283-6. [DOI: 10.1053/j.gastro.2018.06.081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
272 Khan S, Imran A, Malik A, Chaudhary AA, Rub A, Jan AT, Syed JB, Rolfo C. Bacterial imbalance and gut pathologies: Association and contribution of E. coli in inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences 2019;56:1-17. [DOI: 10.1080/10408363.2018.1517144] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
273 Yao Y, Jin Z, Lee JH. An improved statistical model for taxonomic assignment of metagenomics. BMC Genet 2018;19:98. [PMID: 30373533 DOI: 10.1186/s12863-018-0680-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Robertson SJ, Goethel A, Girardin SE, Philpott DJ. Innate Immune Influences on the Gut Microbiome: Lessons from Mouse Models. Trends Immunol 2018;39:992-1004. [PMID: 30377046 DOI: 10.1016/j.it.2018.10.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
275 Tronstad RR, Polushina T, Brattbakk HR, Stansberg C, von Volkmann HL, Hanevik K, Ellinghaus E, Jørgensen SF, Ersland KM, Pham KD, Gilja OH, Hovdenak N, Hausken T, Vatn MH, Franke A, Knappskog PM, Le Hellard S, Karlsen TH, Fiskerstrand T. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea. Scand J Gastroenterol 2018;53:1264-73. [PMID: 30353760 DOI: 10.1080/00365521.2018.1521867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
276 Jitsumura M, Cunningham AL, Hitchings MD, Islam S, Davies AP, Row PE, Riddell AD, Kinross J, Wilkinson TS, Jenkins GJ, Williams JG, Harris DA. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study. BMJ Open 2018;8:e021987. [PMID: 30341117 DOI: 10.1136/bmjopen-2018-021987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
277 Clavel T, Gomes-Neto JC, Lagkouvardos I, Ramer-Tait AE. Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes. Immunol Rev 2017;279:8-22. [PMID: 28856739 DOI: 10.1111/imr.12578] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
278 Li Z, Zhu H, Zhang L, Qin C. The intestinal microbiome and Alzheimer's disease: A review. Animal Model Exp Med 2018;1:180-8. [PMID: 30891563 DOI: 10.1002/ame2.12033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
279 Zuo T, Ng SC. The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease. Front Microbiol. 2018;9:2247. [PMID: 30319571 DOI: 10.3389/fmicb.2018.02247] [Cited by in Crossref: 190] [Cited by in F6Publishing: 242] [Article Influence: 47.5] [Reference Citation Analysis]
280 Fang H, Fu L, Wang J. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:8941340. [PMID: 30302341 DOI: 10.1155/2018/8941340] [Cited by in Crossref: 23] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
281 Sebastián VP, Salazar GA, Coronado-Arrázola I, Schultz BM, Vallejos OP, Berkowitz L, Álvarez-Lobos MM, Riedel CA, Kalergis AM, Bueno SM. Heme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and Progression. Front Immunol 2018;9:1956. [PMID: 30258436 DOI: 10.3389/fimmu.2018.01956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
282 Karl JP, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, Soares JW. Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota. Front Microbiol 2018;9:2013. [PMID: 30258412 DOI: 10.3389/fmicb.2018.02013] [Cited by in Crossref: 132] [Cited by in F6Publishing: 160] [Article Influence: 33.0] [Reference Citation Analysis]
283 Lopez-Siles M, Enrich-Capó N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects. Front Cell Infect Microbiol 2018;8:281. [PMID: 30245977 DOI: 10.3389/fcimb.2018.00281] [Cited by in Crossref: 94] [Cited by in F6Publishing: 71] [Article Influence: 23.5] [Reference Citation Analysis]
284 Chen JS, Hu F, Kugathasan S, Jorde LB, Nix D, Rutherford A, Denson L, Watkins WS, Prahalad S, Huff C, Guthery SL. Targeted Gene Sequencing in Children with Crohn's Disease and Their Parents: Implications for Missing Heritability. G3 (Bethesda) 2018;8:2881-8. [PMID: 30166421 DOI: 10.1534/g3.118.200404] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 Schäffler H, Schmidt M, Huth A, Reiner J, Glass Ä, Lamprecht G. Clinical factors are associated with vitamin D levels in IBD patients: A retrospective analysis. J Dig Dis 2018;19:24-32. [PMID: 29232067 DOI: 10.1111/1751-2980.12565] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
286 Filipescu IE, Leonardi L, Menchetti L, Guelfi G, Traina G, Casagrande-Proietti P, Piro F, Quattrone A, Barbato O, Brecchia G. Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice. PLoS One 2018;13:e0202929. [PMID: 30138385 DOI: 10.1371/journal.pone.0202929] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
287 Shi Y, Kellingray L, Zhai Q, Gall GL, Narbad A, Zhao J, Zhang H, Chen W. Structural and Functional Alterations in the Microbial Community and Immunological Consequences in a Mouse Model of Antibiotic-Induced Dysbiosis. Front Microbiol 2018;9:1948. [PMID: 30186263 DOI: 10.3389/fmicb.2018.01948] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
288 Ihekweazu FD, Versalovic J. Development of the Pediatric Gut Microbiome: Impact on Health and Disease. Am J Med Sci 2018;356:413-23. [PMID: 30384950 DOI: 10.1016/j.amjms.2018.08.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
289 Chattopadhyay A, Mythili S. The journey of gut microbiome – An introduction and its influence on metabolic disorders. Front Biol 2018;13:327-41. [DOI: 10.1007/s11515-018-1490-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
290 Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol 2018;40:476-82. [PMID: 30111198 DOI: 10.1080/08923973.2018.1469145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
291 Galla S, Chakraborty S, Cheng X, Yeo J, Mell B, Zhang H, Mathew AV, Vijay-Kumar M, Joe B. Disparate effects of antibiotics on hypertension. Physiol Genomics 2018;50:837-45. [PMID: 30095376 DOI: 10.1152/physiolgenomics.00073.2018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
292 Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health 2018;15:E1679. [PMID: 30087270 DOI: 10.3390/ijerph15081679] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 22.8] [Reference Citation Analysis]
293 Filip M, Tzaneva V, Dumitrascu DL. Fecal transplantation: digestive and extradigestive clinical applications. Clujul Med 2018;91:259-65. [PMID: 30093802 DOI: 10.15386/cjmed-946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
294 Hiippala K, Jouhten H, Ronkainen A, Hartikainen A, Kainulainen V, Jalanka J, Satokari R. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients 2018;10:E988. [PMID: 30060606 DOI: 10.3390/nu10080988] [Cited by in Crossref: 143] [Cited by in F6Publishing: 205] [Article Influence: 35.8] [Reference Citation Analysis]
295 Qi Q, Liu YN, Jin XM, Zhang LS, Wang C, Bao CH, Liu HR, Wu HG, Wang XM. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model. World J Gastroenterol 2018; 24(28): 3130-3144 [PMID: 30065559 DOI: 10.3748/wjg.v24.i28.3130] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
296 Micic D, Hirsch A, Setia N, Rubin DT. Enteric infections complicating ulcerative colitis. Intest Res 2018;16:489-93. [PMID: 30090049 DOI: 10.5217/ir.2018.16.3.489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
297 Painold A, Mörkl S, Kashofer K, Halwachs B, Dalkner N, Bengesser S, Birner A, Fellendorf F, Platzer M, Queissner R, Schütze G, Schwarz MJ, Moll N, Holzer P, Holl AK, Kapfhammer HP, Gorkiewicz G, Reininghaus EZ. A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. Bipolar Disord 2019;21:40-9. [PMID: 30051546 DOI: 10.1111/bdi.12682] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 16.5] [Reference Citation Analysis]
298 Basson AR, Lam M, Cominelli F. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. Gastroenterol Clin North Am. 2017;46:689-729. [PMID: 29173517 DOI: 10.1016/j.gtc.2017.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
299 Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G, Karling P, Grip O, Key T, Bergmann MM, Boeing H, Overvad K, Palli D, Masala G, Khaw KT, Racine A, Carbonnel F, Boutron-Ruault MC, Andersen V, Olsen A, Tjonneland A, Kaaks R, Tumino R, Trichopoulou A, Scalbert A, Riboli E, Hart AR. Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis-A Multicenter European Prospective Cohort Study (EPIC). Inflamm Bowel Dis 2017;23:2072-82. [PMID: 28837515 DOI: 10.1097/MIB.0000000000001108] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
300 Azer SA, Azer S. What can we learn from top-cited articles in inflammatory bowel disease? A bibliometric analysis and assessment of the level of evidence. BMJ Open. 2018;8:e021233. [PMID: 30002009 DOI: 10.1136/bmjopen-2017-021233] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
301 Kim DH, Kim S, Lee JH, Kim JH, Che X, Ma HW, Seo DH, Kim TI, Kim WH, Kim SW, Cheon JH. Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress: L. acidophilus and ER-stress pathway. Journal of Gastroenterology and Hepatology 2019;34:178-85. [DOI: 10.1111/jgh.14362] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
302 Grasberger H, Noureldin M, Kao TD, Adler J, Lee JM, Bishu S, El-Zaatari M, Kao JY, Waljee AK. Increased risk for inflammatory bowel disease in congenital hypothyroidism supports the existence of a shared susceptibility factor. Sci Rep 2018;8:10158. [PMID: 29977049 DOI: 10.1038/s41598-018-28586-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
303 Rostami FM, Mousavi H, Mousavi MRN, Shahsafi M. Efficacy of Probiotics in Prevention and Treatment of Infectious Diseases. Clinical Microbiology Newsletter 2018;40:97-103. [DOI: 10.1016/j.clinmicnews.2018.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
304 Tronstad RR, Kummen M, Holm K, von Volkmann HL, Anmarkrud JA, Høivik ML, Moum B, Gilja OH, Hausken T, Baines J, Karlsen TH, Fiskerstrand T, Hov JR. Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease. Inflamm Bowel Dis 2017;23:1752-61. [PMID: 28902124 DOI: 10.1097/MIB.0000000000001264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
305 Morgillo F, Dallio M, Della Corte CM, Gravina AG, Viscardi G, Loguercio C, Ciardiello F, Federico A. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota. Neoplasia 2018;20:721-33. [PMID: 29859426 DOI: 10.1016/j.neo.2018.05.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
306 Schultz BM, Salazar GA, Paduro CA, Pardo-Roa C, Pizarro DP, Salazar-Echegarai FJ, Torres J, Riedel CA, Kalergis AM, Álvarez-Lobos MM, Bueno SM. Persistent Salmonella enterica serovar Typhimurium Infection Increases the Susceptibility of Mice to Develop Intestinal Inflammation. Front Immunol 2018;9:1166. [PMID: 29896196 DOI: 10.3389/fimmu.2018.01166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
307 Yoon H, Schaubeck M, Lagkouvardos I, Blesl A, Heinzlmeir S, Hahne H, Clavel T, Panda S, Ludwig C, Kuster B, Manichanh C, Kump P, Haller D, Hörmannsperger G. Increased Pancreatic Protease Activity in Response to Antibiotics Impairs Gut Barrier and Triggers Colitis. Cell Mol Gastroenterol Hepatol 2018;6:370-388.e3. [PMID: 30182050 DOI: 10.1016/j.jcmgh.2018.05.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
308 Jeon SR, Chai J, Kim C, Lee CH. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Curr Infect Dis Rep 2018;20:21. [PMID: 29804272 DOI: 10.1007/s11908-018-0627-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
309 Escher U, Giladi E, Dunay IR, Bereswill S, Gozes I, Heimesaat MM. Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis. Eur J Microbiol Immunol (Bp) 2018;8:34-40. [PMID: 29997909 DOI: 10.1556/1886.2018.00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
310 Williamson IA, Arnold JW, Samsa LA, Gaynor L, DiSalvo M, Cocchiaro JL, Carroll I, Azcarate-Peril MA, Rawls JF, Allbritton NL, Magness ST. A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 2018;6:301-19. [PMID: 30123820 DOI: 10.1016/j.jcmgh.2018.05.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 98] [Article Influence: 20.8] [Reference Citation Analysis]
311 Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N, Bouziat R, Buscarlet M, Ringus DL, Wang Y, Li Y, Dinh V, Kim SM, McDonald BD, Zurenski MA, Musch MW, Furtado GC, Lira SA, Baier G, Chang EB, Eren AM, Weber CR, Busque L, Godley LA, Verdú EF, Barreiro LB, Jabri B. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 2018;557:580-4. [PMID: 29769727 DOI: 10.1038/s41586-018-0125-z] [Cited by in Crossref: 124] [Cited by in F6Publishing: 163] [Article Influence: 31.0] [Reference Citation Analysis]
312 Collins J, Auchtung JM. Control of Clostridium difficile Infection by Defined Microbial Communities. Microbiol Spectr 2017;5. [PMID: 28936948 DOI: 10.1128/microbiolspec.BAD-0009-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
313 Binda C, Lopetuso LR, Rizzatti G, Gibiino G, Cennamo V, Gasbarrini A. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Digestive and Liver Disease 2018;50:421-8. [DOI: 10.1016/j.dld.2018.02.012] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 23.0] [Reference Citation Analysis]
314 Schäffler H, Herlemann DP, Klinitzke P, Berlin P, Kreikemeyer B, Jaster R, Lamprecht G. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls. J Dig Dis 2018;19:225-34. [PMID: 29573237 DOI: 10.1111/1751-2980.12591] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 11.5] [Reference Citation Analysis]
315 Klimesova K, Jiraskova Zakostelska Z, Tlaskalova-Hogenova H. Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis. Front Microbiol 2018;9:774. [PMID: 29731748 DOI: 10.3389/fmicb.2018.00774] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
316 Mamantopoulos M, Ronchi F, McCoy KD, Wullaert A. Inflammasomes make the case for littermate-controlled experimental design in studying host-microbiota interactions. Gut Microbes 2018;9:374-81. [PMID: 29672197 DOI: 10.1080/19490976.2017.1421888] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
317 Lennon EM, Borst LB, Edwards LL, Moeser AJ. Mast Cells Exert Anti-Inflammatory Effects in an IL10<sup>-/-</sup> Model of Spontaneous Colitis. Mediators Inflamm. 2018;2018:7817360. [PMID: 29849494 DOI: 10.1155/2018/7817360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
318 Taylor JM, Clarke EL, Baker K, Lauder A, Kim D, Bailey A, Wu GD, Collman RG, Doyle-Meyers L, Russell-Lodrigue K, Blanchard J, Bushman FD, Bohm R. Evaluation of a therapy for Idiopathic Chronic Enterocolitis in rhesus macaques (Macaca mulatta) and linked microbial community correlates. PeerJ 2018;6:e4612. [PMID: 29666764 DOI: 10.7717/peerj.4612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
319 Ma HQ, Yu TT, Zhao XJ, Zhang Y, Zhang HJ. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease. World J Gastroenterol 2018; 24(13): 1464-1477 [PMID: 29632427 DOI: 10.3748/wjg.v24.i13.1464] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
320 Gilbert MS, Ijssennagger N, Kies AK, van Mil SWC. Protein fermentation in the gut; implications for intestinal dysfunction in humans, pigs, and poultry. Am J Physiol Gastrointest Liver Physiol 2018;315:G159-70. [PMID: 29597354 DOI: 10.1152/ajpgi.00319.2017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
321 Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V, Ajami NJ, Petrosino JF, Gerardin Y, Kassam Z, Smith M, Iliev ID, Sonnenberg GF, Artis D, Scherl E, Longman RS. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Inflamm Bowel Dis 2017;23:903-11. [PMID: 28445246 DOI: 10.1097/MIB.0000000000001132] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 16.0] [Reference Citation Analysis]
322 Liu YH, Ding Y, Gao CC, Li LS, Wang YX, Xu JD. Functional macrophages and gastrointestinal disorders. World J Gastroenterol 2018; 24(11): 1181-1195 [PMID: 29568199 DOI: 10.3748/wjg.v24.i11.1181] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
323 Schäffler H, Rohde M, Rohde S, Huth A, Gittel N, Hollborn H, Koczan D, Glass Ä, Lamprecht G, Jaster R. NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients. World J Gastroenterol 2018; 24(11): 1196-1205 [PMID: 29568200 DOI: 10.3748/wjg.v24.i11.1196] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
324 Zhang B, Liu Y, Lan X, Xu X, Zhang X, Li X, Zhao Y, Li G, Du C, Lu S, Wang H. Oral Escherichia coli expressing IL-35 meliorates experimental colitis in mice. J Transl Med 2018;16:71. [PMID: 29554971 DOI: 10.1186/s12967-018-1441-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
325 Kappelman MD, Lange A, Randell RL, Basta PV, Sandler RS, Laugesen K, Byrjalsen A, Christensen T, Frøslev T, Erichsen R. Feasibility of salivary DNA collection in a population-based case-control study: a pilot study of pediatric Crohn's disease. Clin Epidemiol 2018;10:215-22. [PMID: 29535554 DOI: 10.2147/CLEP.S143322] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
326 El Mouzan M, Wang F, Al Mofarreh M, Menon R, Al Barrag A, Korolev KS, Al Sarkhy A, Al Asmi M, Hamed Y, Saeed A, Dowd SE, Assiri A, Winter H. Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease. J Crohns Colitis 2017;11:586-92. [PMID: 27811291 DOI: 10.1093/ecco-jcc/jjw197] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
327 Constante M, Fragoso G, Lupien-Meilleur J, Calvé A, Santos MM. Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis. Inflamm Bowel Dis 2017;23:753-66. [PMID: 28368910 DOI: 10.1097/MIB.0000000000001089] [Cited by in Crossref: 56] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
328 Bourgonje AR, von Martels JZH, de Vos P, Faber KN, Dijkstra G. Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines. PLoS One 2018;13:e0193202. [PMID: 29466406 DOI: 10.1371/journal.pone.0193202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
329 Alexeev EE, Lanis JM, Kao DJ, Campbell EL, Kelly CJ, Battista KD, Gerich ME, Jenkins BR, Walk ST, Kominsky DJ, Colgan SP. Microbiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 Receptor. Am J Pathol 2018;188:1183-94. [PMID: 29454749 DOI: 10.1016/j.ajpath.2018.01.011] [Cited by in Crossref: 110] [Cited by in F6Publishing: 153] [Article Influence: 27.5] [Reference Citation Analysis]
330 Wu W, Chen F, Liu Z, Cong Y. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:1473-82. [PMID: 27057688 DOI: 10.1097/MIB.0000000000000775] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
331 Cheng J, Xue F, Zhang M, Cheng C, Qiao L, Ma J, Sui W, Xu X, Gao C, Hao P, Zhang M, Zhang Y. TRIM31 Deficiency Is Associated with Impaired Glucose Metabolism and Disrupted Gut Microbiota in Mice. Front Physiol 2018;9:24. [PMID: 29497383 DOI: 10.3389/fphys.2018.00024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
332 Heath RD, Cockerell C, Mankoo R, Ibdah JA, Tahan V. Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders. North Clin Istanb. 2018;5:79-88. [PMID: 29607440 DOI: 10.14744/nci.2017.10692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
333 Sarabi Asiabar A, Asadzadeh Aghdaei H, Sabokbar A, Zali MR, Feizabadi MM. Investigation of adherent-invasive E. coli in patients with Crohn's disease. Med J Islam Repub Iran 2018;32:11. [PMID: 30159262 DOI: 10.14196/mjiri.32.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
334 Dogan B, Fu J, Zhang S, Scherl EJ, Simpson KW. Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses. J Antibiot (Tokyo) 2018;71:485-94. [PMID: 29410518 DOI: 10.1038/s41429-017-0022-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
335 Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, Li T, Yin Y. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Front Cell Infect Microbiol. 2018;8:13. [PMID: 29468141 DOI: 10.3389/fcimb.2018.00013] [Cited by in Crossref: 330] [Cited by in F6Publishing: 450] [Article Influence: 82.5] [Reference Citation Analysis]
336 Shi Y, Zhao X, Zhao J, Zhang H, Zhai Q, Narbad A, Chen W. A mixture of Lactobacillus species isolated from traditional fermented foods promote recovery from antibiotic-induced intestinal disruption in mice. J Appl Microbiol 2018;124:842-54. [PMID: 29314490 DOI: 10.1111/jam.13687] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
337 Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, Stintzi A, Mack D. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease. Inflamm Bowel Dis. 2016;22:1533-1539. [PMID: 27271491 DOI: 10.1097/mib.0000000000000776] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
338 D'Auria E, Mameli C, Piras C, Cococcioni L, Urbani A, Zuccotti GV, Roncada P. Precision medicine in cow's milk allergy: proteomics perspectives from allergens to patients. J Proteomics 2018;188:173-80. [PMID: 29408543 DOI: 10.1016/j.jprot.2018.01.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
339 Aygun H, Karamese M, Ozic C, Uyar F. The effects of mucosal media on some pathogenic traits of Crohn's disease-associated Escherichia coli LF82. Future Microbiology 2018;13:141-9. [DOI: 10.2217/fmb-2017-0133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
340 Pagliari D, Saviano A, Newton EE, Serricchio ML, Dal Lago AA, Gasbarrini A, Cianci R. Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders. Mediators Inflamm 2018;2018:7946431. [PMID: 29563853 DOI: 10.1155/2018/7946431] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
341 Rohr M, Narasimhulu CA, Sharma D, Doomra M, Riad A, Naser S, Parthasarathy S. Inflammatory Diseases of the Gut. J Med Food 2018;21:113-26. [PMID: 29389238 DOI: 10.1089/jmf.2017.0138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
342 Doss GA, Mans C, Johnson L, Pinkerton ME, Hardie RJ, Sladky KK. Diagnosis and management of inflammatory bowel disease in a harpy eagle (Harpia harpyja) with suspected fenbendazole toxicosis. J Am Vet Med Assoc 2018;252:336-42. [PMID: 29346050 DOI: 10.2460/javma.252.3.336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
343 Atherly T, Mosher C, Wang C, Hostetter J, Proctor A, Brand MW, Phillips GJ, Wannemuehler M, Jergens AE. Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice. Inflamm Bowel Dis 2016;22:2571-81. [PMID: 27755267 DOI: 10.1097/MIB.0000000000000944] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
344 Glover LE, Fennimore B, Wingfield M. Inflammatory Bowel Disease: Influence and Implications in Reproduction. Inflamm Bowel Dis 2016;22:2724-32. [PMID: 27537054 DOI: 10.1097/MIB.0000000000000884] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
345 Mullineaux-Sanders C, Suez J, Elinav E, Frankel G. Sieving through gut models of colonization resistance. Nat Microbiol 2018;3:132-40. [PMID: 29358683 DOI: 10.1038/s41564-017-0095-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
346 Li N, Shi RH. Updated review on immune factors in pathogenesis of Crohn’s disease. World J Gastroenterol 2018; 24(1): 15-22 [PMID: 29358878 DOI: 10.3748/wjg.v24.i1.15] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
347 Pacheco MT, Vezza T, Diez-echave P, Utrilla P, Villamiel M, Moreno FJ. Anti-inflammatory bowel effect of industrial orange by-products in DSS-treated mice. Food Funct 2018;9:4888-96. [DOI: 10.1039/c8fo01060a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
348 Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1-10. [PMID: 29285689 DOI: 10.1007/s12328-017-0813-5] [Cited by in Crossref: 308] [Cited by in F6Publishing: 284] [Article Influence: 61.6] [Reference Citation Analysis]
349 Malikowski T, Khanna S, Pardi DS. Fecal microbiota transplantation for gastrointestinal disorders. Curr Opin Gastroenterol 2017;33:8-13. [PMID: 28134687 DOI: 10.1097/MOG.0000000000000326] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
350 Peura S, Fall T, Almqvist C, Andolf E, Hedman A, Pershagen G, Helmersson-karlqvist J, Larsson A. Normal values for calprotectin in stool samples of infants from the population-based longitudinal born into life study. Scandinavian Journal of Clinical and Laboratory Investigation 2018;78:120-4. [DOI: 10.1080/00365513.2017.1420216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
351 Heimesaat MM, Giladi E, Kühl AA, Bereswill S, Gozes I. The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis. Peptides 2018;101:1-9. [PMID: 29288684 DOI: 10.1016/j.peptides.2017.12.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
352 Ogaugwu CE, Cheng Q, Fieck A, Hurwitz I, Durvasula R. Characterization of a Lactococcus lactis promoter for heterologous protein production. Biotechnol Rep (Amst) 2018;17:86-92. [PMID: 29541600 DOI: 10.1016/j.btre.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
353 Gomes-Neto JC, Kittana H, Mantz S, Segura Munoz RR, Schmaltz RJ, Bindels LB, Clarke J, Hostetter JM, Benson AK, Walter J, Ramer-Tait AE. A gut pathobiont synergizes with the microbiota to instigate inflammatory disease marked by immunoreactivity against other symbionts but not itself. Sci Rep 2017;7:17707. [PMID: 29255158 DOI: 10.1038/s41598-017-18014-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
354 Segal JP, Oke S, Hold GL, Clark SK, Faiz OD, Hart AL. Systematic review: ileoanal pouch microbiota in health and disease. Aliment Pharmacol Ther 2018;47:466-77. [PMID: 29205422 DOI: 10.1111/apt.14454] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
355 Zhang SL, Wang SN, Miao CY. Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention. Front Immunol 2017;8:1674. [PMID: 29234327 DOI: 10.3389/fimmu.2017.01674] [Cited by in Crossref: 48] [Cited by in F6Publishing: 64] [Article Influence: 9.6] [Reference Citation Analysis]
356 Fawkner-Corbett D, Simmons A, Parikh K. Microbiome, pattern recognition receptor function in health and inflammation. Best Pract Res Clin Gastroenterol. 2017;31:683-691. [PMID: 29566912 DOI: 10.1016/j.bpg.2017.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
357 Antonangeli F, Soriani A, Cerboni C, Sciumè G, Santoni A. How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation. Front Immunol 2017;8:1583. [PMID: 29209320 DOI: 10.3389/fimmu.2017.01583] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
358 Kusunoki Y, Kido Y, Naito Y, Kon R, Mizukami N, Kaneko M, Wakui N, Machida Y, Ikarashi N. Changes in the Pharmacokinetics of Phenytoin in Dextran Sulfate Sodium–Induced Ulcerative Colitis in Mice. Int J Toxicol 2017;36:485-91. [DOI: 10.1177/1091581817735987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
359 Witkowski M, Witkowski M, Gagliani N, Huber S. Recipe for IBD: can we use food to control inflammatory bowel disease? Semin Immunopathol 2018;40:145-56. [PMID: 29124320 DOI: 10.1007/s00281-017-0658-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
360 Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: A Common Factor in Human Diseases. Biomed Res Int. 2017;2017:9351507. [PMID: 29230419 DOI: 10.1155/2017/9351507] [Cited by in Crossref: 239] [Cited by in F6Publishing: 323] [Article Influence: 47.8] [Reference Citation Analysis]
361 Alba C MA, Daya M, Franck C. Tart Cherries and health: Current knowledge and need for a better understanding of the fate of phytochemicals in the human gastrointestinal tract. Crit Rev Food Sci Nutr 2019;59:626-38. [PMID: 28956621 DOI: 10.1080/10408398.2017.1384918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
362 Wang T, Zhao H. Constructing Predictive Microbial Signatures at Multiple Taxonomic Levels. Journal of the American Statistical Association 2017;112:1022-31. [DOI: 10.1080/01621459.2016.1270213] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
363 Pandey N, Rajagopal R. Tissue damage induced midgut stem cell proliferation and microbial dysbiosis in Spodoptera litura. FEMS Microbiology Ecology 2017;93. [DOI: 10.1093/femsec/fix132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
364 Pagliari D, Gambassi G, Piccirillo CA, Cianci R. The Intricate Link among Gut "Immunological Niche," Microbiota, and Xenobiotics in Intestinal Pathology. Mediators Inflamm 2017;2017:8390595. [PMID: 29118468 DOI: 10.1155/2017/8390595] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
365 Elhenawy W, Oberc A, Coombes BK. A polymicrobial view of disease potential in Crohn's-associated adherent-invasive E. coli. Gut Microbes 2018;9:166-74. [PMID: 28914579 DOI: 10.1080/19490976.2017.1378291] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
366 Kouki MI, Papadimitriou SA, Psalla D, Kolokotronis A, Rallis TS. Chronic Gingivostomatitis with Esophagitis in Cats. J Vet Intern Med 2017;31:1673-9. [PMID: 28960466 DOI: 10.1111/jvim.14850] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
367 Chung SY, Ravel J, Regan M. Clinical Relevance of Gastrointestinal Microbiota During Pregnancy: A Primer for Nurses. Biol Res Nurs 2018;20:84-102. [PMID: 28954525 DOI: 10.1177/1099800417732412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
368 Constante M, Fragoso G, Calvé A, Samba-Mondonga M, Santos MM. Dietary Heme Induces Gut Dysbiosis, Aggravates Colitis, and Potentiates the Development of Adenomas in Mice. Front Microbiol 2017;8:1809. [PMID: 28983289 DOI: 10.3389/fmicb.2017.01809] [Cited by in Crossref: 54] [Cited by in F6Publishing: 66] [Article Influence: 10.8] [Reference Citation Analysis]
369 Ward-Hartstonge KA, Kemp RA. Regulatory T-cell heterogeneity and the cancer immune response. Clin Transl Immunology. 2017;6:e154. [PMID: 28983402 DOI: 10.1038/cti.2017.43] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 12.0] [Reference Citation Analysis]
370 Sharpton T, Lyalina S, Luong J, Pham J, Deal EM, Armour C, Gaulke C, Sanjabi S, Pollard KS. Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice. mSystems 2017;2:e00036-17. [PMID: 28904997 DOI: 10.1128/mSystems.00036-17] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
371 Tamzaourte M, Errabih I, Krami H, Maha F, Maria L, Benzzoubeir N, Ouazzani L, Sefiani A, Ouazzani H. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease]. Pan Afr Med J 2017;27:116. [PMID: 28819537 DOI: 10.11604/pamj.2017.27.116.9187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
372 Glymenaki M, Barnes A, O'Hagan S, Warhurst G, McBain AJ, Wilson ID, Kell DB, Else KJ, Cruickshank SM. Stability in metabolic phenotypes and inferred metagenome profiles before the onset of colitis-induced inflammation. Sci Rep 2017;7:8836. [PMID: 28821731 DOI: 10.1038/s41598-017-08732-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
373 Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Front Immunol 2017;8:942. [PMID: 28855901 DOI: 10.3389/fimmu.2017.00942] [Cited by in Crossref: 105] [Cited by in F6Publishing: 149] [Article Influence: 21.0] [Reference Citation Analysis]
374 Wang L, Yu YM, Zhang YQ, Zhang J, Lu N, Liu N. Hydrogen breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in autism. Eur Child Adolesc Psychiatry 2018;27:233-40. [PMID: 28799094 DOI: 10.1007/s00787-017-1039-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
375 Kang P, Wang X, Wu H, Zhu H, Hou Y, Wang L, Liu Y. Glutamate alleviates muscle protein loss by modulating TLR4, NODs, Akt/FOXO and mTOR signaling pathways in LPS-challenged piglets. PLoS One 2017;12:e0182246. [PMID: 28783736 DOI: 10.1371/journal.pone.0182246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
376 Aranda-olmedo I, Ruiz R, Peinado MJ, Rubio LA. A pea (Pisum sativum L.) seed albumin extract prevents colonic DSS induced dysbiosis in mice. Journal of Functional Foods 2017;35:279-94. [DOI: 10.1016/j.jff.2017.05.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
377 Statovci D, Aguilera M, MacSharry J, Melgar S. The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. Front Immunol. 2017;8:838. [PMID: 28804483 DOI: 10.3389/fimmu.2017.00838] [Cited by in Crossref: 163] [Cited by in F6Publishing: 182] [Article Influence: 32.6] [Reference Citation Analysis]
378 Khanna S, Raffals LE. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies. Gastroenterol Clin North Am. 2017;46:481-492. [PMID: 28838410 DOI: 10.1016/j.gtc.2017.05.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
379 Bajer L, Kverka M, Kostovcik M, Macinga P, Dvorak J, Stehlikova Z, Brezina J, Wohl P, Spicak J, Drastich P. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J Gastroenterol 2017; 23(25): 4548-4558 [PMID: 28740343 DOI: 10.3748/wjg.v23.i25.4548] [Cited by in CrossRef: 172] [Cited by in F6Publishing: 140] [Article Influence: 34.4] [Reference Citation Analysis]
380 Khajah MA. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease. Scand J Gastroenterol 2017;52:1172-84. [PMID: 28685630 DOI: 10.1080/00365521.2017.1347812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
381 Asquith MJ, Stauffer P, Davin S, Mitchell C, Lin P, Rosenbaum JT. Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis. Arthritis Rheumatol 2016;68:2151-62. [PMID: 26992013 DOI: 10.1002/art.39681] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
382 Ren Z, Jiang J, Xie H, Li A, Lu H, Xu S, Zhou L, Zhang H, Cui G, Chen X, Liu Y, Wu L, Qin N, Sun R, Wang W, Li L, Zheng S. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China. Oncotarget. 2017;8:95176-95191. [PMID: 29221120 DOI: 10.18632/oncotarget.18820] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
383 Bernier-Latmani J, Petrova TV. Intestinal lymphatic vasculature: structure, mechanisms and functions. Nat Rev Gastroenterol Hepatol 2017;14:510-26. [PMID: 28655884 DOI: 10.1038/nrgastro.2017.79] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 20.4] [Reference Citation Analysis]
384 Hudak JE, Alvarez D, Skelly A, von Andrian UH, Kasper DL. Illuminating vital surface molecules of symbionts in health and disease. Nat Microbiol 2017;2:17099. [PMID: 28650431 DOI: 10.1038/nmicrobiol.2017.99] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
385 Coutinho HDM, de Morais Oliveira-Tintino CD, Tintino SR, Pereira RLS, de Freitas TS, da Silva MAP, Franco JL, da Cunha FAB, da Costa JGM, de Menezes IRA, Boligon AA, da Rocha JBT, Rocha MI, Dos Santos JFS. Toxicity against Drosophila melanogaster and antiedematogenic and antimicrobial activities of Alternanthera brasiliana (L.) Kuntze (Amaranthaceae). Environ Sci Pollut Res Int 2018;25:10353-61. [PMID: 28597384 DOI: 10.1007/s11356-017-9366-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
386 Gyuraszova M, Kovalcikova A, Gardlik R. Association between oxidative status and the composition of intestinal microbiota along the gastrointestinal tract. Medical Hypotheses 2017;103:81-5. [DOI: 10.1016/j.mehy.2017.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
387 Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol 2017;15:465-78. [PMID: 28529325 DOI: 10.1038/nrmicro.2017.44] [Cited by in Crossref: 205] [Cited by in F6Publishing: 222] [Article Influence: 41.0] [Reference Citation Analysis]
388 Ihara S, Hirata Y, Koike K. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol 2017;52:777-87. [PMID: 28534191 DOI: 10.1007/s00535-017-1350-1] [Cited by in Crossref: 117] [Cited by in F6Publishing: 111] [Article Influence: 23.4] [Reference Citation Analysis]
389 刘玥宏, 丁悦, 徐敬东. 肠道杯状细胞及其功能研究进展. 世界华人消化杂志 2017; 25(14): 1279-1286 [DOI: 10.11569/wcjd.v25.i14.1279] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
390 Qiu Z, Yang H, Rong L, Ding W, Chen J, Zhong L. Targeted Metagenome Based Analyses Show Gut Microbial Diversity of Inflammatory Bowel Disease patients. Indian J Microbiol. 2017;57:307-315. [PMID: 28904415 DOI: 10.1007/s12088-017-0652-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
391 Zhang Z, Shen P, Lu X, Li Y, Liu J, Liu B, Fu Y, Cao Y, Zhang N. In Vivo and In Vitro Study on the Efficacy of Terpinen-4-ol in Dextran Sulfate Sodium-Induced Mice Experimental Colitis. Front Immunol. 2017;8:558. [PMID: 28553294 DOI: 10.3389/fimmu.2017.00558] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
392 Hart ML, Ericsson AC, Franklin CL. Differing Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease. Front Microbiol 2017;8:792. [PMID: 28553262 DOI: 10.3389/fmicb.2017.00792] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
393 Galla S, Chakraborty S, Mell B, Vijay-Kumar M, Joe B. Microbiotal-Host Interactions and Hypertension. Physiology (Bethesda) 2017;32:224-33. [PMID: 28404738 DOI: 10.1152/physiol.00003.2017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
394 Kang M, Martin A. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Semin Immunol 2017;32:3-13. [PMID: 28465070 DOI: 10.1016/j.smim.2017.04.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 78] [Article Influence: 12.6] [Reference Citation Analysis]
395 MacLellan A, Moore-Connors J, Grant S, Cahill L, Langille MGI, Van Limbergen J. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review. Nutrients 2017;9:E0447. [PMID: 28468301 DOI: 10.3390/nu9050447] [Cited by in Crossref: 37] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
396 Borton MA, Sabag-Daigle A, Wu J, Solden LM, O'Banion BS, Daly RA, Wolfe RA, Gonzalez JF, Wysocki VH, Ahmer BMM, Wrighton KC. Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome. Microbiome 2017;5:47. [PMID: 28449706 DOI: 10.1186/s40168-017-0264-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
397 Aguirre JE, Winston JH, Sarna SK. Neonatal immune challenge followed by adult immune challenge induces epigenetic-susceptibility to aggravated visceral hypersensitivity. Neurogastroenterol Motil 2017;29. [PMID: 28439935 DOI: 10.1111/nmo.13081] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
398 Chiriac MT, Mahapatro M, Neurath MF, Becker C. The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond. Visc Med 2017;33:153-62. [PMID: 28560232 DOI: 10.1159/000470892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
399 Saeed MA, Ng GZ, Däbritz J, Wagner J, Judd L, Han J, Dhar P, Kirkwood CD, Sutton P. Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity: . Inflammatory Bowel Diseases 2017;23:593-602. [DOI: 10.1097/mib.0000000000001045] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
400 Bhattacharyya S, Shumard T, Xie H, Dodda A, Varady KA, Feferman L, Halline AG, Goldstein JL, Hanauer SB, Tobacman JK. A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutr Healthy Aging 2017;4:181-92. [PMID: 28447072 DOI: 10.3233/NHA-170023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
401 Rapozo DCM, Bernardazzi C, de Souza HSP. Diet and microbiota in inflammatory bowel disease: The gut in disharmony. World J Gastroenterol 2017; 23(12): 2124-2140 [PMID: 28405140 DOI: 10.3748/wjg.v23.i12.2124] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 70] [Article Influence: 16.6] [Reference Citation Analysis]
402 Eck A, de Groot EFJ, de Meij TGJ, Welling M, Savelkoul PHM, Budding AE. Robust Microbiota-Based Diagnostics for Inflammatory Bowel Disease. J Clin Microbiol 2017;55:1720-32. [PMID: 28330889 DOI: 10.1128/JCM.00162-17] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
403 Dar MJ, Ali H, Khan A, Khan GM. Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa. Journal of Drug Targeting 2017;25:582-96. [DOI: 10.1080/1061186x.2017.1298601] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
404 Haskey N, Gibson DL. An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. Nutrients 2017;9:E259. [PMID: 28287412 DOI: 10.3390/nu9030259] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
405 Schultz BM, Paduro CA, Salazar GA, Salazar-Echegarai FJ, Sebastián VP, Riedel CA, Kalergis AM, Alvarez-Lobos M, Bueno SM. A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases. Front Immunol 2017;8:191. [PMID: 28293241 DOI: 10.3389/fimmu.2017.00191] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
406 Ijaz UZ, Quince C, Hanske L, Loman N, Calus ST, Bertz M, Edwards CA, Gaya DR, Hansen R, McGrogan P, Russell RK, Gerasimidis K. The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically-linked kindred. PLoS One 2017;12:e0172605. [PMID: 28222161 DOI: 10.1371/journal.pone.0172605] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
407 Wang B, Yao M, Lv L, Ling Z, Li L. The Human Microbiota in Health and Disease. Engineering 2017;3:71-82. [DOI: 10.1016/j.eng.2017.01.008] [Cited by in Crossref: 266] [Article Influence: 53.2] [Reference Citation Analysis]
408 Stremmel W, Schmidt KV, Schuhmann V, Kratzer F, Garbade SF, Langhans CD, Fricker G, Okun JG. Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine. PLoS One 2017;12:e0170742. [PMID: 28129384 DOI: 10.1371/journal.pone.0170742] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
409 Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B, Overvad K, Palli D, Masala G, Carbonnel F, Boutron-Ruault MC, Olsen A, Tjonneland A, Kaaks R, Katzke V, Riboli E, Hart AR. No association of alcohol use and the risk of ulcerative colitis or Crohn's disease: data from a European Prospective cohort study (EPIC). Eur J Clin Nutr. 2017;71:512-518. [PMID: 28120853 DOI: 10.1038/ejcn.2016.271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
410 Deroover L, Verspreet J, Luypaerts A, Vandermeulen G, Courtin CM, Verbeke K. Wheat Bran Does Not Affect Postprandial Plasma Short-Chain Fatty Acids from 13C-inulin Fermentation in Healthy Subjects. Nutrients 2017;9:E83. [PMID: 28117694 DOI: 10.3390/nu9010083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
411 Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J Gastroenterol. 2015;65:215-221. [PMID: 25896155 DOI: 10.4166/kjg.2015.65.4.215] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
412 Cuív PÓ, Begun J, Keely S, Lewindon PJ, Morrison M. Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn's disease. Food Funct 2016;7:1741-51. [PMID: 26948398 DOI: 10.1039/c5fo01196e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
413 Liu YH, Xu JD. Relationship between colonic inner mucus layer and pathogenesis of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 77-83 [DOI: 10.11569/wcjd.v25.i1.77] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
414 Alnabhani Z, Hugot JP, Montcuquet N, Le Roux K, Dussaillant M, Roy M, Leclerc M, Cerf-Bensussan N, Lepage P, Barreau F. Respective Roles of Hematopoietic and Nonhematopoietic Nod2 on the Gut Microbiota and Mucosal Homeostasis. Inflamm Bowel Dis 2016;22:763-73. [PMID: 26963567 DOI: 10.1097/MIB.0000000000000749] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
415 Kim MS, Byun JS, Yoon YS, Yum DY, Chung MJ, Lee JC. A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production. Benef Microbes 2017;8:231-41. [PMID: 28008786 DOI: 10.3920/BM2016.0031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
416 Hughes M, Qazi T, Berg A, Weinberg J, Chen X, Kelly CP, Farraye FA. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2016;22:853-61. [PMID: 26954708 DOI: 10.1097/MIB.0000000000000696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
417 Heimesaat MM, Grundmann U, Alutis ME, Fischer A, Bereswill S. Microbiota Composition and Immune Responses During Campylobacter Jejuni Infection in Conventionally Colonized IL-10-/- Mice Lacking Nucleotide Oligomerization Domain 2. Eur J Microbiol Immunol (Bp) 2017;7:1-14. [PMID: 28386467 DOI: 10.1556/1886.2016.00038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
418 Moschen AR, Gerner RR, Wang J, Klepsch V, Adolph TE, Reider SJ, Hackl H, Pfister A, Schilling J, Moser PL, Kempster SL, Swidsinski A, Orth Höller D, Weiss G, Baines JF, Kaser A, Tilg H. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host Microbe 2016;19:455-69. [PMID: 27078067 DOI: 10.1016/j.chom.2016.03.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 156] [Article Influence: 19.5] [Reference Citation Analysis]
419 Gao S, Wu X, Zhang Y, Li K, Wang L, Liu G. Tripterygium wilfordii polyglycosidium ameliorates pouchitis induced by dextran sulfate sodium in rats. Int Immunopharmacol 2017;43:108-15. [PMID: 27988458 DOI: 10.1016/j.intimp.2016.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
420 Roy A, Lichtiger S. Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease. Inflamm Bowel Dis 2016;22:648-53. [PMID: 26650148 DOI: 10.1097/MIB.0000000000000641] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
421 Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) 2016;6:253-71. [PMID: 27980855 DOI: 10.1556/1886.2016.00036] [Cited by in Crossref: 67] [Cited by in F6Publishing: 74] [Article Influence: 11.2] [Reference Citation Analysis]
422 Robinson AM, Gondalia SV, Karpe AV, Eri R, Beale DJ, Morrison PD, Palombo EA, Nurgali K. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016;22:2767-87. [DOI: 10.1097/mib.0000000000000970] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
423 Kwong Chung CK, Ronchi F, Geuking MB. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology 2017;150:221-35. [PMID: 27779311 DOI: 10.1111/imm.12682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
424 Yeom Y, Kim BS, Kim SJ, Kim Y. Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium-induced colitis mice. BMC Complement Altern Med 2016;16:481. [PMID: 27884149 DOI: 10.1186/s12906-016-1456-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
425 Górska S, Sandstrőm C, Wojas-Turek J, Rossowska J, Pajtasz-Piasecka E, Brzozowska E, Gamian A. Structural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel disease. Sci Rep 2016;6:37613. [PMID: 27869188 DOI: 10.1038/srep37613] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
426 Kumar M, Kissoon-Singh V, Coria AL, Moreau F, Chadee K. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2017;312:G34-G45. [PMID: 27856417 DOI: 10.1152/ajpgi.00298.2016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
427 Jeon YD, Bang KS, Shin MK, Lee JH, Chang YN, Jin JS. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med 2016;16:459. [PMID: 27846836 DOI: 10.1186/s12906-016-1390-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
428 Rieder F, Kurada S, Grove D, Cikach F, Lopez R, Patel N, Singh A, Alkhouri N, Shen B, Brzezinski A, Baker M, Fiocchi C, Dweik RA. A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications. Clin Transl Gastroenterol 2016;7:e201. [PMID: 27831543 DOI: 10.1038/ctg.2016.57] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
429 Fofanova TY, Petrosino JF, Kellermayer R. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases. J Pediatr Gastroenterol Nutr 2016;62:208-19. [PMID: 26308318 DOI: 10.1097/MPG.0000000000000950] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
430 Dunn KA, Moore-connors J, Macintyre B, Stadnyk A, Thomas NA, Noble A, Mahdi G, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. The Gut Microbiome of Pediatric Crohnʼs Disease Patients Differs from Healthy Controls in Genes That Can Influence the Balance Between a Healthy and Dysregulated Immune Response: . Inflammatory Bowel Diseases 2016;22:2607-18. [DOI: 10.1097/mib.0000000000000949] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
431 Albenberg L, Kelsen J. Advances in Gut Microbiome Research and Relevance to Pediatric Diseases. The Journal of Pediatrics 2016;178:16-23. [DOI: 10.1016/j.jpeds.2016.08.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
432 Jones RM, Neish AS. Redox signaling mediated by the gut microbiota. Free Radic Biol Med 2017;105:41-7. [PMID: 27989756 DOI: 10.1016/j.freeradbiomed.2016.10.495] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 10.8] [Reference Citation Analysis]
433 Vasovic M, Gajovic N, Brajkovic D, Jovanovic M, Zdravkovaic N, Kanjevac T. The relationship between the immune system and oral manifestations of inflammatory bowel disease: a review. Cent Eur J Immunol. 2016;41:302-310. [PMID: 27833449 DOI: 10.5114/ceji.2016.63131] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
434 Ellermann M, Arthur JC. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic Biol Med 2017;105:68-78. [PMID: 27780750 DOI: 10.1016/j.freeradbiomed.2016.10.489] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
435 Paściak M, Górska S, Jawiarczyk N, Gamian A. Lactobacillus johnsonii glycolipids, their structure and immunoreactivity with sera from inflammatory bowel disease patients. Microb Biotechnol 2017;10:456-68. [PMID: 27766756 DOI: 10.1111/1751-7915.12424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
436 Sartor RB, Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology 2017; 152: 327-339. e4. [PMID: 27769810 DOI: 10.1053/j.gastro.2016.10.012] [Cited by in Crossref: 332] [Cited by in F6Publishing: 393] [Article Influence: 55.3] [Reference Citation Analysis]
437 Sugi Y, Takahashi K, Kurihara K, Nakata K, Narabayashi H, Hamamoto Y, Suzuki M, Tsuda M, Hanazawa S, Hosono A, Kaminogawa S. Post-Transcriptional Regulation of Toll-Interacting Protein in the Intestinal Epithelium. PLoS One 2016;11:e0164858. [PMID: 27741296 DOI: 10.1371/journal.pone.0164858] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
438 Small CL, Xing L, McPhee JB, Law HT, Coombes BK. Acute Infectious Gastroenteritis Potentiates a Crohn's Disease Pathobiont to Fuel Ongoing Inflammation in the Post-Infectious Period. PLoS Pathog. 2016;12:e1005907. [PMID: 27711220 DOI: 10.1371/journal.ppat.1005907] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
439 Heo J, Seo M, Park H, Lee WK, Guan LL, Yoon J, Caetano-Anolles K, Ahn H, Kim SY, Kang YM, Cho S, Kim H. Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice. Sci Rep 2016;6:33566. [PMID: 27658722 DOI: 10.1038/srep33566] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
440 Thomann AK, Thomann PA, Wolf RC, Hirjak D, Schmahl C, Ebert MP, Szabo K, Reindl W, Griebe M. Altered Markers of Brain Development in Crohn's Disease with Extraintestinal Manifestations - A Pilot Study. PLoS One 2016;11:e0163202. [PMID: 27655165 DOI: 10.1371/journal.pone.0163202] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
441 Friedrich K, Smit M, Brune M, Giese T, Rupp C, Wannhoff A, Kloeters P, Leopold Y, Denk GU, Weiss KH, Stremmel W, Sauer P, Hohenester S, Schirmacher P, Schemmer P, Gotthardt DN. CD14 is associated with biliary stricture formation. Hepatology 2016;64:843-52. [PMID: 26970220 DOI: 10.1002/hep.28543] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
442 Kleiman SC, Watson HJ, Bulik-Sullivan EC, Huh EY, Tarantino LM, Bulik CM, Carroll IM. The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom Med 2015;77:969-81. [PMID: 26428446 DOI: 10.1097/PSY.0000000000000247] [Cited by in Crossref: 136] [Cited by in F6Publishing: 71] [Article Influence: 22.7] [Reference Citation Analysis]
443 Dotan I, Levy-Nissenbaum E, Chowers Y, Fich A, Israeli E, Adar T, Shteingart S, Soreq H, Goldin E. Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial. Dig Dis Sci 2016;61:3246-54. [PMID: 27572942 DOI: 10.1007/s10620-016-4276-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
444 Kusunoki Y, Ikarashi N, Matsuda S, Matsukawa Y, Kitaoka S, Kon R, Tajima M, Wakui N, Ochiai W, Machida Y, Sugiyama K. Expression of hepatic cytochrome P450 in a mouse model of ulcerative colitis changes with pathological conditions. J Gastroenterol Hepatol 2015;30:1618-26. [PMID: 25867644 DOI: 10.1111/jgh.12966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
445 Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol 2016; 22(29): 6638-6651 [PMID: 27547007 DOI: 10.3748/wjg.v22.i29.6638] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
446 Pérez-Brocal V, García-López R, Nos P, Beltrán B, Moret I, Moya A. Metagenomic Analysis of Crohn's Disease Patients Identifies Changes in the Virome and Microbiome Related to Disease Status and Therapy, and Detects Potential Interactions and Biomarkers. Inflamm Bowel Dis 2015;21:2515-32. [PMID: 26313691 DOI: 10.1097/MIB.0000000000000549] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
447 Hashash JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, Regueiro MD, Baidoo L, Swoger JM, Barrie A, Schwartz M, Dunn MA, Binion DG. Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study. Inflamm Bowel Dis 2015;21:2576-82. [PMID: 26296061 DOI: 10.1097/MIB.0000000000000534] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
448 Basson A, Trotter A, Rodriguez-Palacios A, Cominelli F. Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol. 2016;7:290. [PMID: 27531998 DOI: 10.3389/fimmu.2016.00290] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 10.2] [Reference Citation Analysis]
449 Eppinga H, Fuhler GM, Peppelenbosch MP, Hecht GA. Gut Microbiota Developments With Emphasis on Inflammatory Bowel Disease: Report From the Gut Microbiota for Health World Summit 2016. Gastroenterology 2016;151:e1-4. [DOI: 10.1053/j.gastro.2016.06.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
450 Liu P, Han L, Wang F, Petrenko VA, Liu A. Gold nanoprobe functionalized with specific fusion protein selection from phage display and its application in rapid, selective and sensitive colorimetric biosensing of Staphylococcus aureus. Biosensors and Bioelectronics 2016;82:195-203. [DOI: 10.1016/j.bios.2016.03.075] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
451 Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol 2016; 22(27): 6296-6317 [PMID: 27468219 DOI: 10.3748/wjg.v22.i27.6296] [Cited by in CrossRef: 106] [Cited by in F6Publishing: 92] [Article Influence: 17.7] [Reference Citation Analysis]
452 Nagata Y, Watanabe T, Nagasaka K, Yamada M, Murai M, Takeuchi S, Murase M, Yazaki T, Murase T, Komatsu K, Kaizuka M, Sano M, Asano K, Ando C, Taniuchi N. Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis. BMC Complement Altern Med 2016;16:207. [PMID: 27402114 DOI: 10.1186/s12906-016-1182-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
453 Sun J. Dirty environment for adult life: The bad, the good, the unknown. Genes Dis 2016;3:167-8. [PMID: 30258886 DOI: 10.1016/j.gendis.2016.07.001] [Reference Citation Analysis]
454 Bernardazzi C, Pêgo B, de Souza HS. Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease. Mediators Inflamm 2016;2016:1363818. [PMID: 27471349 DOI: 10.1155/2016/1363818] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
455 Hwang IY, Koh E, Kim HR, Yew WS, Chang MW. Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria. Drug Resistance Updates 2016;27:59-71. [DOI: 10.1016/j.drup.2016.06.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
456 Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016;65:1100-9. [PMID: 26045138 DOI: 10.1136/gutjnl-2014-309059] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 24.0] [Reference Citation Analysis]
457 Grasman ME, van der Sluis WB, de Boer NK. Neovaginal Sparing in a Transgender Woman With Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2016;14:e73-4. [DOI: 10.1016/j.cgh.2016.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
458 de Bruyn M, Vandooren J, Ugarte-berzal E, Arijs I, Vermeire S, Opdenakker G. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016;51:295-358. [DOI: 10.1080/10409238.2016.1199535] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
459 Li K, Xiao Y, Chen J, Chen J, He X, Yang H. Microbial composition in different gut locations of weaning piglets receiving antibiotics. Asian-Australas J Anim Sci 2017;30:78-84. [PMID: 27383806 DOI: 10.5713/ajas.16.0285] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
460 Deda O, Chatziioannou AC, Fasoula S, Palachanis D, Raikos Ν, Theodoridis GA, Gika HG. Sample preparation optimization in fecal metabolic profiling. J Chromatogr B Analyt Technol Biomed Life Sci 2017;1047:115-23. [PMID: 27423778 DOI: 10.1016/j.jchromb.2016.06.047] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 8.0] [Reference Citation Analysis]
461 Nicklas W, Keubler L, Bleich A. Maintaining and Monitoring the Defined Microbiota Status of Gnotobiotic Rodents. ILAR J 2015;56:241-9. [PMID: 26323633 DOI: 10.1093/ilar/ilv029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
462 Lopetuso LR, Scaldaferri F, Franceschi F, Gasbarrini A. Bacillus clausii and gut homeostasis: state of the art and future perspectives. Expert Rev Gastroenterol Hepatol 2016;10:943-8. [PMID: 27291780 DOI: 10.1080/17474124.2016.1200465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
463 Shamran H, Singh NP, Zumbrun EE, Murphy A, Taub DD, Mishra MK, Price RL, Chatterjee S, Nagarkatti M, Nagarkatti PS, Singh UP. Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation. Brain Behav Immun 2017;59:10-20. [PMID: 27327245 DOI: 10.1016/j.bbi.2016.06.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
464 Shi Y, Dong Y, Huang W, Zhu D, Mao H, Su P. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One. 2016;11:e0157259. [PMID: 27295210 DOI: 10.1371/journal.pone.0157259] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 9.0] [Reference Citation Analysis]
465 Simon JM, Davis JP, Lee SE, Schaner MR, Gipson GR, Weiser M, Sartor RB, Herfarth HH, Rahbar R, Sadiq TS. Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses. Eur J Immunol. 2016;46:1912-1925. [PMID: 27159132 DOI: 10.1002/eji.201546237] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
466 Mondot S, Lepage P, Seksik P, Allez M, Tréton X, Bouhnik Y, Colombel JF, Leclerc M, Pochart P, Doré J, Marteau P; GETAID. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery. Gut 2016;65:954-62. [PMID: 26628508 DOI: 10.1136/gutjnl-2015-309184] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
467 Zou Y, Xiang Q, Wang J, Peng J, Wei H. Oregano Essential Oil Improves Intestinal Morphology and Expression of Tight Junction Proteins Associated with Modulation of Selected Intestinal Bacteria and Immune Status in a Pig Model. Biomed Res Int 2016;2016:5436738. [PMID: 27314026 DOI: 10.1155/2016/5436738] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
468 Zhang PW, Yang CW, Ji SN, Wang B. Gut microbiota and related diseases. Shijie Huaren Xiaohua Zazhi 2016; 24(15): 2355-2360 [DOI: 10.11569/wcjd.v24.i15.2355] [Reference Citation Analysis]
469 Schäffler H, Herlemann DPR, Alberts C, Kaschitzki A, Bodammer P, Bannert K, Köller T, Warnke P, Kreikemeyer B, Lamprecht G. Mucosa-attached bacterial community in Crohn's disease coheres with the clinical disease activity index. Environ Microbiol Rep 2016;8:614-21. [PMID: 27083382 DOI: 10.1111/1758-2229.12411] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
470 Bein A, Zilbershtein A, Golosovsky M, Davidov D, Schwartz B. LPS Induces Hyper-Permeability of Intestinal Epithelial Cells. J Cell Physiol 2017;232:381-90. [PMID: 27191060 DOI: 10.1002/jcp.25435] [Cited by in Crossref: 55] [Cited by in F6Publishing: 68] [Article Influence: 9.2] [Reference Citation Analysis]
471 Keubler LM, Buettner M, Häger C, Bleich A. A Multihit Model: Colitis Lessons from the Interleukin-10-deficient Mouse. Inflamm Bowel Dis 2015;21:1967-75. [PMID: 26164667 DOI: 10.1097/MIB.0000000000000468] [Cited by in Crossref: 135] [Cited by in F6Publishing: 82] [Article Influence: 22.5] [Reference Citation Analysis]
472 Wu C, Xu Z, Gai R, Huang K. Matrine ameliorates spontaneously developed colitis in interleukin-10-deficient mice. Int Immunopharmacol. 2016;36:256-262. [PMID: 27179305 DOI: 10.1016/j.intimp.2016.04.038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
473 Singh VP, Proctor SD, Willing BP. Koch's postulates, microbial dysbiosis and inflammatory bowel disease. Clin Microbiol Infect 2016;22:594-9. [PMID: 27179648 DOI: 10.1016/j.cmi.2016.04.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
474 Couter CJ, Surana NK. Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes. J Vis Exp 2016. [PMID: 27213538 DOI: 10.3791/54114] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
475 Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
476 Etienne-Mesmin L, Vijay-Kumar M, Gewirtz AT, Chassaing B. Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease. Cell Mol Gastroenterol Hepatol. 2016;2:584-604. [PMID: 28090564 DOI: 10.1016/j.jcmgh.2016.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 9.5] [Reference Citation Analysis]
477 Hernández-Chirlaque C, Aranda CJ, Ocón B, Capitán-Cañadas F, Ortega-González M, Carrero JJ, Suárez MD, Zarzuelo A, Sánchez de Medina F, Martínez-Augustin O. Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis. J Crohns Colitis 2016;10:1324-35. [PMID: 27117829 DOI: 10.1093/ecco-jcc/jjw096] [Cited by in Crossref: 84] [Cited by in F6Publishing: 108] [Article Influence: 14.0] [Reference Citation Analysis]
478 Munyaka PM, Rabbi MF, Khafipour E, Ghia JE. Acute dextran sulfate sodium (DSS)-induced colitis promotes gut microbial dysbiosis in mice. J Basic Microbiol. 2016;56:986-998. [PMID: 27112251 DOI: 10.1002/jobm.201500726] [Cited by in Crossref: 95] [Cited by in F6Publishing: 124] [Article Influence: 15.8] [Reference Citation Analysis]
479 Ihara S, Hirata Y, Serizawa T, Suzuki N, Sakitani K, Kinoshita H, Hayakawa Y, Nakagawa H, Ijichi H, Tateishi K, Koike K. TGF-β Signaling in Dendritic Cells Governs Colonic Homeostasis by Controlling Epithelial Differentiation and the Luminal Microbiota. J I 2016;196:4603-13. [DOI: 10.4049/jimmunol.1502548] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
480 Jeon YD, Kang SH, Bang KS, Chang YN, Lee JH, Jin JS. Glycyrrhetic Acid Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Vivo. Molecules 2016;21:523. [PMID: 27110761 DOI: 10.3390/molecules21040523] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
481 Matijašić M, Meštrović T, Perić M, Čipčić Paljetak H, Panek M, Vranešić Bender D, Ljubas Kelečić D, Krznarić Ž, Verbanac D. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci 2016;17:E578. [PMID: 27104515 DOI: 10.3390/ijms17040578] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
482 Stecher B. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Microbiol Spectr 2015;3. [PMID: 26185088 DOI: 10.1128/microbiolspec.MBP-0008-2014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
483 Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016;9:606-625. [PMID: 27366227 DOI: 10.1177/1756283x16644242] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 14.8] [Reference Citation Analysis]
484 Miner-williams WM, Moughan PJ. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel. Nutr Res Rev 2016;29:40-59. [DOI: 10.1017/s0954422416000019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
485 Tanaka Y, Ito S, Isobe K. Vancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils. Sci Rep 2016;6:23920. [PMID: 27050089 DOI: 10.1038/srep23920] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
486 Laubitz D, Harrison CA, Midura-Kiela MT, Ramalingam R, Larmonier CB, Chase JH, Caporaso JG, Besselsen DG, Ghishan FK, Kiela PR. Reduced Epithelial Na+/H+ Exchange Drives Gut Microbial Dysbiosis and Promotes Inflammatory Response in T Cell-Mediated Murine Colitis. PLoS One 2016;11:e0152044. [PMID: 27050757 DOI: 10.1371/journal.pone.0152044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
487 Munyaka PM, Sepehri S, Ghia JE, Khafipour E. Carrageenan Gum and Adherent Invasive Escherichia coli in a Piglet Model of Inflammatory Bowel Disease: Impact on Intestinal Mucosa-associated Microbiota. Front Microbiol 2016;7:462. [PMID: 27092122 DOI: 10.3389/fmicb.2016.00462] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
488 Belle A, Baumann C, Bigard MA, Zallot C, Gizard E, Guéant JL, Bronowicki JP, Peyrin-Biroulet L. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2015;27:877-81. [PMID: 26121376 DOI: 10.1097/MEG.0000000000000370] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
489 Yan LJ, Tang QY. Role of intestinal microbiota and fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2016; 24(9): 1386-1392 [DOI: 10.11569/wcjd.v24.i9.1386] [Reference Citation Analysis]
490 Venè R, Tosetti F, Minghelli S, Poggi A, Ferrari N, Benelli R. Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation. Oncotarget 2015;6:12310-25. [PMID: 25987127 DOI: 10.18632/oncotarget.3678] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
491 Hennessy AA, Ross PR, Fitzgerald GF, Stanton C. Sources and Bioactive Properties of Conjugated Dietary Fatty Acids. Lipids 2016;51:377-97. [PMID: 26968402 DOI: 10.1007/s11745-016-4135-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
492 Schäffler H, Kaschitzki A, Alberts C, Bodammer P, Bannert K, Köller T, Warnke P, Kreikemeyer B, Lamprecht G. Alterations in the mucosa-associated bacterial composition in Crohn’s disease: a pilot study. Int J Colorectal Dis 2016;31:961-71. [DOI: 10.1007/s00384-016-2548-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
493 Buttó LF, Haller D. Dysbiosis in intestinal inflammation: Cause or consequence. Int J Med Microbiol 2016;306:302-9. [PMID: 27012594 DOI: 10.1016/j.ijmm.2016.02.010] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 11.5] [Reference Citation Analysis]
494 Wang K, Xu R, Snider AJ, Schrandt J, Li Y, Bialkowska AB, Li M, Zhou J, Hannun YA, Obeid LM, Yang VW, Mao C. Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system. Cell Death Dis 2016;7:e2124. [PMID: 26938296 DOI: 10.1038/cddis.2016.36] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
495 Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol. 2016;9:229-239. [PMID: 26929784 DOI: 10.1177/1756283x15607414] [Cited by in Crossref: 142] [Cited by in F6Publishing: 156] [Article Influence: 23.7] [Reference Citation Analysis]
496 Bloemendaal AL, Buchs NC, George BD, Guy RJ. Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery 2016;159:1237-48. [PMID: 26936524 DOI: 10.1016/j.surg.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
497 Rosen MJ, Dhawan A, Saeed SA. Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr. 2015;169:1053-1060. [PMID: 26414706 DOI: 10.1001/jamapediatrics.2015.1982] [Cited by in Crossref: 192] [Cited by in F6Publishing: 231] [Article Influence: 32.0] [Reference Citation Analysis]
498 Yu B, Dai CQ, Chen J, Deng L, Wu XL, Wu S, Zhao CL, Jiang ZY, Chen XY. Dysbiosis of gut microbiota induced the disorder of helper T cells in influenza virus-infected mice. Hum Vaccin Immunother 2015;11:1140-6. [PMID: 25874358 DOI: 10.1080/21645515.2015.1009805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
499 Hetemäki I, Jarva H, Kluger N, Baldauf HM, Laakso S, Bratland E, Husebye ES, Kisand K, Ranki A, Peterson P, Arstila TP. Anticommensal Responses Are Associated with Regulatory T Cell Defect in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients. J Immunol 2016;196:2955-64. [PMID: 26903483 DOI: 10.4049/jimmunol.1500301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
500 Morales Fénero CI, Colombo Flores AA, Câmara NOS. Inflammatory diseases modelling in zebrafish. World J Exp Med 2016; 6(1): 9-20 [PMID: 26929916 DOI: 10.5493/wjem.v6.i1.9] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
501 Reinoso Webb C, Koboziev I, Furr KL, Grisham MB. Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology. 2016;23:67-80. [PMID: 26947707 DOI: 10.1016/j.pathophys.2016.02.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
502 Burgis JC, Nguyen K, Park K, Cox K. Response to strict and liberalized specific carbohydrate diet in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(6): 2111-2117 [PMID: 26877615 DOI: 10.3748/wjg.v22.i6.2111] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
503 Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G, O'Keefe S, Meng B, Song D, Zhang Y. Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflamm Bowel Dis. 2015;21:1419-1427. [PMID: 25939040 DOI: 10.1097/mib.0000000000000344] [Cited by in Crossref: 34] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
504 Steimle A, Frick JS. Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice. J Immunol Res 2016;2016:1958650. [PMID: 26981546 DOI: 10.1155/2016/1958650] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
505 Tian Z, Liu J, Liao M, Li W, Zou J, Han X, Kuang M, Shen W, Li H. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice. Dig Dis Sci. 2016; Feb 5. [Epub ahead of print]. [PMID: 26846120 DOI: 10.1007/s10620-016-4060-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
506 Huang EY, Inoue T, Leone VA, Dalal S, Touw K, Wang Y, Musch MW, Theriault B, Higuchi K, Donovan S, Gilbert J, Chang EB. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflamm Bowel Dis 2015;21:963-72. [PMID: 25738379 DOI: 10.1097/MIB.0000000000000332] [Cited by in Crossref: 105] [Cited by in F6Publishing: 52] [Article Influence: 17.5] [Reference Citation Analysis]
507 Cui Y, Wei H, Lu F, Liu X, Liu D, Gu L, Ouyang C. Different Effects of Three Selected Lactobacillus Strains in Dextran Sulfate Sodium-Induced Colitis in BALB/c Mice. PLoS One 2016;11:e0148241. [PMID: 26840426 DOI: 10.1371/journal.pone.0148241] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
508 Derikx LA, Dieleman LA, Hoentjen F. Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2016;30:55-71. [DOI: 10.1016/j.bpg.2016.02.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
509 Valcheva R, Dieleman LA. Prebiotics: Definition and protective mechanisms. Best Practice & Research Clinical Gastroenterology 2016;30:27-37. [DOI: 10.1016/j.bpg.2016.02.008] [Cited by in Crossref: 78] [Cited by in F6Publishing: 51] [Article Influence: 13.0] [Reference Citation Analysis]
510 Schaubeck M, Clavel T, Calasan J, Lagkouvardos I, Haange SB, Jehmlich N, Basic M, Dupont A, Hornef M, von Bergen M, Bleich A, Haller D. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut 2016;65:225-37. [PMID: 25887379 DOI: 10.1136/gutjnl-2015-309333] [Cited by in Crossref: 227] [Cited by in F6Publishing: 209] [Article Influence: 37.8] [Reference Citation Analysis]
511 Gloux K, Anba-Mondoloni J. Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives. PLoS One 2016;11:e0148291. [PMID: 26824357 DOI: 10.1371/journal.pone.0148291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
512 Liverani E, Scaioli E, Digby RJ, Bellanova M, Belluzzi A. How to predict clinical relapse in inflammatory bowel disease patients. World J Gastroenterol 2016; 22(3): 1017-1033 [PMID: 26811644 DOI: 10.3748/wjg.v22.i3.1017] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 59] [Article Influence: 11.3] [Reference Citation Analysis]
513 Jadhav SR, Shandilya UK, Kansal VK. Immunoprotective Effect of Probiotic Dahi Containing Lactobacillus acidophilus and Bifidobacterium bifidum on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice. Probiotics Antimicrob Proteins 2012;4:21-6. [PMID: 26781733 DOI: 10.1007/s12602-011-9087-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
514 Fiocchi C. Inflammatory bowel disease pathogenesis: where are we? J Gastroenterol Hepatol. 2015;30 Suppl 1:12-18. [PMID: 25827798 DOI: 10.1111/jgh.12751] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
515 Gómez-Hurtado I, Such J, Francés R. Microbiome and bacterial translocation in cirrhosis. Gastroenterol Hepatol 2016;39:687-96. [PMID: 26775042 DOI: 10.1016/j.gastrohep.2015.10.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
516 Gungor B, Adiguzel E, Gursel I, Yilmaz B, Gursel M. Intestinal Microbiota in Patients with Spinal Cord Injury. PLoS One. 2016;11:e0145878. [PMID: 26752409 DOI: 10.1371/journal.pone.0145878] [Cited by in Crossref: 60] [Cited by in F6Publishing: 72] [Article Influence: 10.0] [Reference Citation Analysis]
517 Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A. Gut microbiota in autism and mood disorders. World J Gastroenterol 2016; 22(1): 361-368 [PMID: 26755882 DOI: 10.3748/wjg.v22.i1.361] [Cited by in CrossRef: 217] [Cited by in F6Publishing: 181] [Article Influence: 36.2] [Reference Citation Analysis]
518 Kim MS, Bang JH, Lee J, Han JS, Kang HW, Jeon WK. Fructus mume Ethanol Extract Prevents Inflammation and Normalizes the Septohippocampal Cholinergic System in a Rat Model of Chronic Cerebral Hypoperfusion. J Med Food 2016;19:196-204. [PMID: 26714236 DOI: 10.1089/jmf.2015.3512] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
519 McPhee JB, Schertzer JD. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci (Lond) 2015;129:1083-96. [PMID: 26464517 DOI: 10.1042/CS20150431] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
520 Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2015;21:912-22. [PMID: 25581832 DOI: 10.1097/MIB.0000000000000289] [Cited by in Crossref: 59] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
521 Goldsmith JR, Kelly M, Freeman KB, Duro D. Combined restitutive therapy for treatment of immunosuppressive refractory Crohn disease. J Pediatr Gastroenterol Nutr 2015;60:e31-4. [PMID: 24121152 DOI: 10.1097/MPG.0000000000000191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
522 Dogan S, Guven K, Celikbilek M, Deniz K, Saraymen B, Gursoy S. Serum Visfatin Levels in Ulcerative Colitis. J Clin Lab Anal 2016;30:552-6. [PMID: 26668098 DOI: 10.1002/jcla.21901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
523 Panagi M, Georgila K, Eliopoulos AG, Apidianakis Y. Constructing personalized longitudinal holo'omes of colon cancer-prone humans and their modeling in flies and mice. Oncotarget 2019;10:4224-46. [PMID: 31289620 DOI: 10.18632/oncotarget.6463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
524 Polanco Allué I. Microbiota and gastrointestinal diseases. Anales de Pediatría (English Edition) 2015;83:443.e1-5. [DOI: 10.1016/j.anpede.2015.11.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
525 Nickerson KP, Chanin R, McDonald C. Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin. Gut Microbes. 2015;6:78-83. [PMID: 25738413 DOI: 10.1080/19490976.2015.1005477] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
526 Nakamura K, Sakuragi N, Takakuwa A, Ayabe T. Paneth cell α-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health 2016;35:57-67. [PMID: 27200259 DOI: 10.12938/bmfh.2015-019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
527 Buttó LF, Schaubeck M, Haller D. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol 2015;6:555. [PMID: 26635787 DOI: 10.3389/fimmu.2015.00555] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
528 Alzahal O, Valdes EV, Mcbride BW. Analysis of the distal gut bacterial community by 454-pyrosequencing in captive giraffes ( Giraffa camelopardalis ): Distal Gut Bacterial Community in Captive Giraffe. Zoo Biology 2016;35:42-50. [DOI: 10.1002/zoo.21252] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
529 Polanco Allué I. [Microbiota and gastrointestinal diseases]. An Pediatr (Barc) 2015;83:443.e1-5. [PMID: 26534880 DOI: 10.1016/j.anpedi.2015.07.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
530 Brotherton CS, Taylor AG, Bourguignon C, Anderson JG. A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease. Gastroenterol Nurs. 2014;37:206-216. [PMID: 24871666 DOI: 10.1097/sga.0000000000000047] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
531 Oberc A, Coombes BK. Convergence of External Crohn's Disease Risk Factors on Intestinal Bacteria. Front Immunol 2015;6:558. [PMID: 26579131 DOI: 10.3389/fimmu.2015.00558] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
532 Park SH, Kim D, Kim J, Moon Y. Effects of Mycotoxins on mucosal microbial infection and related pathogenesis. Toxins (Basel) 2015;7:4484-502. [PMID: 26529017 DOI: 10.3390/toxins7114484] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
533 Shi HY, Chan FK, Leung WK, Li MK, Leung CM, Sze SF, Ching JY, Lo FH, Tsang SW, Shan EH, Mak LY, Lam BC, Hui AJ, Wong SH, Wong MT, Hung IF, Hui YT, Chan YK, Chan KH, Loo CK, Tong RW, Chow WH, Ng CK, Lao WC, Harbord M, Wu JC, Sung JJ, Ng SC. Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry. J Crohns Colitis 2016;10:176-85. [PMID: 26512132 DOI: 10.1093/ecco-jcc/jjv194] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
534 Larmonier CB, Shehab KW, Ghishan FK, Kiela PR. T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome. Biomed Res Int. 2015;2015:504638. [PMID: 26583115 DOI: 10.1155/2015/504638] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
535 Harris N. Immunology: Chronic effects of acute infections. Nature 2015;526:509-10. [PMID: 26490613 DOI: 10.1038/526509a] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
536 Britton LE, Cassidy JP, O'Donovan J, Gordon SV, Markey B. Potential application of emerging diagnostic techniques to the diagnosis of bovine Johne's disease (paratuberculosis). Vet J 2016;209:32-9. [PMID: 26831164 DOI: 10.1016/j.tvjl.2015.10.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
537 Peat CM, Kleiman SC, Bulik CM, Carroll IM. The Intestinal Microbiome in Bariatric Surgery Patients. Eur Eat Disord Rev 2015;23:496-503. [PMID: 26426680 DOI: 10.1002/erv.2400] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
538 Sadaghian Sadabad M, Regeling A, de Goffau MC, Blokzijl T, Weersma RK, Penders J, Faber KN, Harmsen HJ, Dijkstra G. The ATG16L1-T300A allele impairs clearance of pathosymbionts in the inflamed ileal mucosa of Crohn's disease patients. Gut 2015;64:1546-52. [PMID: 25253126 DOI: 10.1136/gutjnl-2014-307289] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 9.3] [Reference Citation Analysis]
539 Karimi MA, Banifatemeh F, Hatefi-mehrjardi A, Tavallali H, Eshaghia Z, Deilamy-rad G. A novel rapid synthesis of Fe2O3/graphene nanocomposite using ferrate(VI) and its application as a new kind of nanocomposite modified electrode as electrochemical sensor. Materials Research Bulletin 2015;70:856-64. [DOI: 10.1016/j.materresbull.2015.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
540 Mackos AR, Galley JD, Eubank TD, Easterling RS, Parry NM, Fox JG, Lyte M, Bailey MT. Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri. Mucosal Immunol 2016;9:515-26. [PMID: 26422754 DOI: 10.1038/mi.2015.81] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
541 Haag LM, Siegmund B. Intestinal microbiota and the innate immune system - A crosstalk in crohn's disease pathogenesis. Front Immunol. 2015;6:489. [PMID: 26441993 DOI: 10.3389/fimmu.2015.00489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
542 Heimesaat MM, Fischer A, Kühl AA, Göbel UB, Gozes I, Bereswill S. Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice. Eur J Microbiol Immunol (Bp) 2015;5:210-20. [PMID: 26495132 DOI: 10.1556/1886.2015.00025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
543 Landy J, Walker AW, Li JV, Al-Hassi HO, Ronde E, English NR, Mann ER, Bernardo D, McLaughlin SD, Parkhill J. Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci Rep. 2015;5:12955. [PMID: 26264409 DOI: 10.1038/srep12955] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 7.7] [Reference Citation Analysis]
544 Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World J Gastroenterol 2015; 21(29): 8787-8803 [PMID: 26269668 DOI: 10.3748/wjg.v21.i29.8787] [Cited by in CrossRef: 1087] [Cited by in F6Publishing: 886] [Article Influence: 155.3] [Reference Citation Analysis]
545 Schwartz E. Perioperative Parenteral Nutrition in Adults With Inflammatory Bowel Disease: A Review of the Literature. Nutr Clin Pract 2016;31:159-70. [DOI: 10.1177/0884533615594011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
546 Liang J, Sha SM, Wu KC. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases. J Dig Dis 2014;15:641-6. [PMID: 25389085 DOI: 10.1111/1751-2980.12211] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
547 Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A, Rittich B, Kozakova H, Schabussova I. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLoS One. 2015;10:e0134050. [PMID: 26218526 DOI: 10.1371/journal.pone.0134050] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 12.6] [Reference Citation Analysis]
548 Anderson JL, Hedin CR, Benjamin JL, Koutsoumpas A, Ng SC, Hart AL, Forbes A, Stagg AJ, Lindsay JO, Whelan K. Dietary intake of inulin-type fructans in active and inactive Crohn’s disease and healthy controls: a case–control study. ECCOJC 2015;9:1024-31. [DOI: 10.1093/ecco-jcc/jjv136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
549 Ellermann M, Huh EY, Liu B, Carroll IM, Tamayo R, Sartor RB. Adherent-Invasive Escherichia coli Production of Cellulose Influences Iron-Induced Bacterial Aggregation, Phagocytosis, and Induction of Colitis. Infect Immun 2015;83:4068-80. [PMID: 26216423 DOI: 10.1128/IAI.00904-15] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
550 Chan SS, Luben R, van Schaik F, Oldenburg B, Bueno-de-Mesquita HB, Hallmans G, Karling P, Lindgren S, Grip O, Key T. Carbohydrate intake in the etiology of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20:2013-2021. [PMID: 25265262 DOI: 10.1097/mib.0000000000000168] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
551 Low D, Mino-Kenudson M, Mizoguchi E. Recent advancement in understanding colitis-associated tumorigenesis. Inflamm Bowel Dis 2014;20:2115-23. [PMID: 25337866 DOI: 10.1097/MIB.0000000000000094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
552 Holmes E, Wijeyesekera A, Taylor-Robinson SD, Nicholson JK. The promise of metabolic phenotyping in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 2015;12:458-71. [PMID: 26194948 DOI: 10.1038/nrgastro.2015.114] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
553 Tzeng TD, Pao YY, Chen PC, Weng FC, Jean WD, Wang D. Effects of Host Phylogeny and Habitats on Gut Microbiomes of Oriental River Prawn (Macrobrachium nipponense). PLoS One 2015;10:e0132860. [PMID: 26168244 DOI: 10.1371/journal.pone.0132860] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
554 McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, Baji V, Giles EM, Wildemann M, Bashir Z, Whelan K, Sanderson I, Lindsay JO, Stagg AJ. Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. J Clin Invest 2015;125:3215-25. [PMID: 26168223 DOI: 10.1172/JCI80840] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
555 Wu S, Yoon S, Zhang YG, Lu R, Xia Y, Wan J, Petrof EO, Claud EC, Chen D, Sun J. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol 2015;309:G341-9. [PMID: 26159695 DOI: 10.1152/ajpgi.00105.2015] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 9.0] [Reference Citation Analysis]
556 Olofsson KM, Hjertner B, Fossum C, Press CM, Lindberg R. Expression of T helper type 17 (Th17)-associated cytokines and toll-like receptor 4 and their correlation with Foxp3 positive cells in rectal biopsies of horses with clinical signs of inflammatory bowel disease. Vet J 2015;206:97-104. [PMID: 26346261 DOI: 10.1016/j.tvjl.2015.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
557 Guiu J, Jensen KB. From Definitive Endoderm to Gut-a Process of Growth and Maturation. Stem Cells Dev 2015;24:1972-83. [PMID: 26134088 DOI: 10.1089/scd.2015.0017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
558 Kell D, Potgieter M, Pretorius E. Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res 2015;4:179. [PMID: 26629334 DOI: 10.12688/f1000research.6709.2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
559 Strisciuglio C, Miele E, Giugliano FP, Vitale S, Andreozzi M, Vitale A, Catania MR, Staiano A, Troncone R, Gianfrani C. Bifidobacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:1491-8. [DOI: 10.1097/mib.0000000000000389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
560 Kell D, Potgieter M, Pretorius E. Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Res 2015;4:179. [PMID: 26629334 DOI: 10.12688/f1000research.6709.2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
561 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014;48 Suppl 1:S80-4. [PMID: 25291136 DOI: 10.1097/MCG.0000000000000244] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
562 Quezada SM, Rustgi A, Jambaulikar GD, Cross RK. Differential response to microbial antigens by age of diagnosis in patients with Crohn's disease. Clin Exp Gastroenterol 2015;8:169-74. [PMID: 26089697 DOI: 10.2147/CEG.S69905] [Reference Citation Analysis]
563 Izumi H, Minegishi M, Sato Y, Shimizu T, Sekine K, Takase M. Bifidobacterium breve alters immune function and ameliorates DSS-induced inflammation in weanling rats. Pediatr Res. 2015;78:407-416. [PMID: 26083761 DOI: 10.1038/pr.2015.115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
564 Ma C, Maluf HM, Liu TC. Acute graft-versus-host disease is more prevalent and severe in the lower than the upper gastrointestinal tract. Hum Pathol 2015;46:1480-7. [PMID: 26243672 DOI: 10.1016/j.humpath.2015.06.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
565 Ocvirk S, Sava IG, Lengfelder I, Lagkouvardos I, Steck N, Roh JH, Tchaptchet S, Bao Y, Hansen JJ, Huebner J, Carroll IM, Murray BE, Sartor RB, Haller D. Surface-Associated Lipoproteins Link Enterococcus faecalis Virulence to Colitogenic Activity in IL-10-Deficient Mice Independent of Their Expression Levels. PLoS Pathog 2015;11:e1004911. [PMID: 26067254 DOI: 10.1371/journal.ppat.1004911] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
566 Christmann BS, Abrahamsson TR, Bernstein CN, Duck LW, Mannon PJ, Berg G, Björkstén B, Jenmalm MC, Elson CO. Human seroreactivity to gut microbiota antigens. J Allergy Clin Immunol 2015;136:1378-86.e1-5. [PMID: 26014812 DOI: 10.1016/j.jaci.2015.03.036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
567 Nazareth N, Magro F, Machado E, Ribeiro TG, Martinho A, Rodrigues P, Alves R, Macedo GN, Gracio D, Coelho R, Abreu C, Appelberg R, Dias C, Macedo G, Bull T, Sarmento A. Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med Microbiol Immunol 2015;204:681-92. [PMID: 25994082 DOI: 10.1007/s00430-015-0420-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
568 Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res. 2015;2015:489821. [PMID: 26090491 DOI: 10.1155/2015/489821] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 15.3] [Reference Citation Analysis]
569 Pierre JF, Barlow-Anacker AJ, Erickson CS, Heneghan AF, Leverson GE, Dowd SE, Epstein ML, Kudsk KA, Gosain A. Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease. J Pediatr Surg 2014;49:1242-51. [PMID: 25092084 DOI: 10.1016/j.jpedsurg.2014.01.060] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
570 Bustos Fernandez LM, Lasa JS, Man F. Intestinal microbiota: its role in digestive diseases. J Clin Gastroenterol. 2014;48:657-666. [PMID: 24921207 DOI: 10.1097/mcg.0000000000000153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
571 Nitzan M, Mintzer S, Margalit H. Approaches and developments in studying the human microbiome network. Israel J Ecol Evol 2015;61:90-4. [DOI: 10.1080/15659801.2015.1042768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
572 Mishima Y, Liu B, Hansen JJ, Sartor RB. Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling. Cell Mol Gastroenterol Hepatol 2015;1:295-310. [PMID: 26034781 DOI: 10.1016/j.jcmgh.2015.01.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
573 Moghadamrad S, McCoy KD, Geuking MB, Sägesser H, Kirundi J, Macpherson AJ, De Gottardi A. Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels. Hepatology 2015;61:1685-95. [PMID: 25643846 DOI: 10.1002/hep.27698] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
574 Berger G, Bitterman R, Azzam ZS. The human microbiota: the rise of an "empire". Rambam Maimonides Med J 2015;6:e0018. [PMID: 25973270 DOI: 10.5041/RMMJ.10202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
575 Wu XW, Ji HZ, Yang MF, Wu L, Wang FY. Helicobacter pylori infection and inflammatory bowel disease in Asians: A meta-analysis. World J Gastroenterol 2015; 21(15): 4750-4756 [PMID: 25914487 DOI: 10.3748/wjg.v21.i15.4750] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
576 Goldsmith JR. Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation. Healthcare (Basel) 2015;3:219-32. [PMID: 27417758 DOI: 10.3390/healthcare3020219] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
577 Endale M, Aksoylar HI, Hoebe K. Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut. Mediators Inflamm 2015;2015:436017. [PMID: 25944983 DOI: 10.1155/2015/436017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
578 Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn's disease. F1000Prime Rep. 2015;7:44. [PMID: 26097717 DOI: 10.12703/p7-44] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
579 Yang L, Chaudhary N, Baghdadi J, Pei Z. Microbiome in reflux disorders and esophageal adenocarcinoma. Cancer J. 2014;20:207-210. [PMID: 24855009 DOI: 10.1097/ppo.0000000000000044] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
580 Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014;20:1353-1360. [PMID: 24983973 DOI: 10.1097/mib.0000000000000110] [Cited by in Crossref: 151] [Cited by in F6Publishing: 75] [Article Influence: 21.6] [Reference Citation Analysis]
581 Ortiz AM, DiNapoli SR, Brenchley JM. Macrophages Are Phenotypically and Functionally Diverse across Tissues in Simian Immunodeficiency Virus-Infected and Uninfected Asian Macaques. J Virol 2015;89:5883-94. [PMID: 25787286 DOI: 10.1128/JVI.00005-15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
582 Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11:1117-1132. [PMID: 25784453 DOI: 10.1016/j.nano.2015.02.018] [Cited by in Crossref: 217] [Cited by in F6Publishing: 249] [Article Influence: 31.0] [Reference Citation Analysis]
583 Li Q, Wang C, Tang C, He Q, Li N, Li J. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol. 2014;48:513-523. [PMID: 24275714 DOI: 10.1186/s40168-015-0084-7] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 11.1] [Reference Citation Analysis]
584 Utrilla MP, Peinado MJ, Ruiz R, Rodriguez-nogales A, Algieri F, Rodriguez-cabezas ME, Clemente A, Galvez J, Rubio LA. Pea ( Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis. Mol Nutr Food Res 2015;59:807-19. [DOI: 10.1002/mnfr.201400630] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
585 Li Q, Wang C, Tang C, He Q, Li N, Li J. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol 2014;48:513-23. [PMID: 24275714 DOI: 10.1097/MCG.0000000000000035] [Cited by in Crossref: 130] [Cited by in F6Publishing: 86] [Article Influence: 18.6] [Reference Citation Analysis]
586 De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 2015;64:447-58. [PMID: 24811995 DOI: 10.1136/gutjnl-2013-306423] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 17.6] [Reference Citation Analysis]
587 Alnabhani Z, Montcuquet N, Biaggini K, Dussaillant M, Roy M, Ogier-denis E, Madi A, Jallane A, Feuilloley M, Hugot J, Connil N, Barreau F. Pseudomonas fluorescens Alters the Intestinal Barrier Function by Modulating IL-1β Expression Through Hematopoietic NOD2 Signaling: . Inflammatory Bowel Diseases 2015;21:543-55. [DOI: 10.1097/mib.0000000000000291] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
588 García-garcía-de-paredes A, Rodríguez-de-santiago E, Aguilera-castro L, Ferre-aracil C, López-sanromán A. Trasplante de microbiota fecal. Gastroenterología y Hepatología 2015;38:123-34. [DOI: 10.1016/j.gastrohep.2014.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
589 Zhang Y, Zhao F, Deng Y, Zhao Y, Ren H. Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice. J Proteome Res 2015;14:1752-61. [PMID: 25609144 DOI: 10.1021/pr5011263] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
590 Motta V, Soares F, Sun T, Philpott DJ. NOD-like receptors: versatile cytosolic sentinels. Physiol Rev. 2015;95:149-178. [PMID: 25540141 DOI: 10.1152/physrev.00009.2014] [Cited by in Crossref: 161] [Cited by in F6Publishing: 164] [Article Influence: 23.0] [Reference Citation Analysis]
591 Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. 2015;2015:505878. [PMID: 25793197 DOI: 10.1155/2015/505878] [Cited by in Crossref: 150] [Cited by in F6Publishing: 167] [Article Influence: 21.4] [Reference Citation Analysis]
592 Tozer PJ, Rayment N, Hart AL, Daulatzai N, Murugananthan AU, Whelan K, Phillips RKS. What role do bacteria play in persisting fistula formation in idiopathic and Crohn's anal fistula? Colorectal Dis 2015;17:235-41. [DOI: 10.1111/codi.12810] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
593 Berg D, Clemente JC, Colombel JF. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? Expert Rev Gastroenterol Hepatol. 2015;9:781-795. [PMID: 25665875 DOI: 10.1586/17474124.2015.1013031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
594 Chassaing B, Garénaux E, Carriere J, Rolhion N, Guérardel Y, Barnich N, Bonnet R, Darfeuille-Michaud A. Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation. J Bacteriol 2015;197:1451-65. [PMID: 25666140 DOI: 10.1128/JB.02499-14] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
595 Jakaitis BM, Denning PW. Human breast milk and the gastrointestinal innate immune system. Clin Perinatol 2014;41:423-35. [PMID: 24873841 DOI: 10.1016/j.clp.2014.02.011] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 10.6] [Reference Citation Analysis]
596 Ghaleb AM, Laroui H, Merlin D, Yang VW. Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory response. Inflamm Bowel Dis 2014;20:811-20. [PMID: 24681655 DOI: 10.1097/MIB.0000000000000022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
597 Gerasimidis K, Bertz M, Hanske L, Junick J, Biskou O, Aguilera M, Garrick V, Russell RK, Blaut M, McGrogan P, Edwards CA. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis. 2014;20:861-871. [PMID: 24651582 DOI: 10.1097/mib.0000000000000023] [Cited by in Crossref: 147] [Cited by in F6Publishing: 76] [Article Influence: 21.0] [Reference Citation Analysis]
598 Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, Wu GD. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology. 2015;148:1087-1106. [PMID: 25597840 DOI: 10.1053/j.gastro.2015.01.007] [Cited by in Crossref: 194] [Cited by in F6Publishing: 201] [Article Influence: 27.7] [Reference Citation Analysis]
599 Sim M, Kim J. Metagenome assembly through clustering of next-generation sequencing data using protein sequences. J Microbiol Methods 2015;109:180-7. [PMID: 25572018 DOI: 10.1016/j.mimet.2015.01.002] [Reference Citation Analysis]
600 Faith JJ, Colombel JF, Gordon JI. Identifying strains that contribute to complex diseases through the study of microbial inheritance. Proc Natl Acad Sci U S A 2015;112:633-40. [PMID: 25576328 DOI: 10.1073/pnas.1418781112] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
601 Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology 2015;148:1107-19. [PMID: 25575570 DOI: 10.1053/j.gastro.2014.12.036] [Cited by in Crossref: 158] [Cited by in F6Publishing: 148] [Article Influence: 22.6] [Reference Citation Analysis]
602 Sartor RB. Preventing postoperative recurrence of Crohn's disease: how can we improve results? Clin Gastroenterol Hepatol. 2015;13:936-939. [PMID: 25576478 DOI: 10.1016/j.cgh.2014.12.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
603 Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther 2015;149:191-212. [PMID: 25561343 DOI: 10.1016/j.pharmthera.2014.12.006] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 14.4] [Reference Citation Analysis]
604 Li J, Butcher J, Mack D, Stintzi A. Functional Impacts of the Intestinal Microbiome in the Pathogenesis of Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2015;21:139-53. [DOI: 10.1097/mib.0000000000000215] [Cited by in Crossref: 79] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
605 Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2015;308:G351-G363. [PMID: 25540232 DOI: 10.1152/ajpgi.00360.2012] [Cited by in Crossref: 121] [Cited by in F6Publishing: 111] [Article Influence: 15.1] [Reference Citation Analysis]
606 Ianiro G, Bibbò S, Scaldaferri F, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) 2014;93:e97. [PMID: 25340496 DOI: 10.1097/MD.0000000000000097] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
607 Ren Z, Jiang J, Lu H, Chen X, He Y, Zhang H, Xie H, Wang W, Zheng S, Zhou L. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats. Transplantation. 2014;98:844-852. [PMID: 25321166 DOI: 10.1097/tp.0000000000000334] [Cited by in Crossref: 53] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
608 Shahanavaj K, Gil-Bazo I, Castiglia M, Bronte G, Passiglia F, Carreca AP, del Pozo JL, Russo A, Peeters M, Rolfo C. Cancer and the microbiome: potential applications as new tumor biomarker. Expert Rev Anticancer Ther 2015;15:317-30. [PMID: 25495037 DOI: 10.1586/14737140.2015.992785] [Cited by in Crossref: 24] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
609 Schippa S, Conte MP. Dysbiotic events in gut microbiota: impact on human health. Nutrients 2014;6:5786-805. [PMID: 25514560 DOI: 10.3390/nu6125786] [Cited by in Crossref: 96] [Cited by in F6Publishing: 104] [Article Influence: 12.0] [Reference Citation Analysis]
610 Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol. 2014;7:473-487. [PMID: 25525379 DOI: 10.2147/ceg.s27530] [Cited by in Crossref: 57] [Cited by in F6Publishing: 116] [Article Influence: 7.1] [Reference Citation Analysis]
611 Kim MN, Koh SJ, Kim JM, Im JP, Jung HC, Kim JS. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. World J Gastroenterol 2014; 20(45): 17084-17091 [PMID: 25493020 DOI: 10.3748/wjg.v20.i45.17084] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
612 Giannelli V, Di Gregorio V, Iebba V, Giusto M, Schippa S, Merli M, Thalheimer U. Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol 2014; 20(45): 16795-16810 [PMID: 25492994 DOI: 10.3748/wjg.v20.i45.16795] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 121] [Article Influence: 17.6] [Reference Citation Analysis]
613 Wirth R, Bódi N, Maróti G, Bagyánszki M, Talapka P, Fekete É, Bagi Z, Kovács KL. Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One. 2014;9:e110440. [PMID: 25469509 DOI: 10.1371/journal.pone.0110440] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
614 Lopetuso LR, Scaldaferri F, Franceschi F, Gasbarrini A. The gastrointestinal microbiome – Functional interference between stomach and intestine. Best Practice & Research Clinical Gastroenterology 2014;28:995-1002. [DOI: 10.1016/j.bpg.2014.10.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
615 Hartog A, Belle FN, Bastiaans J, de Graaff P, Garssen J, Harthoorn LF, Vos AP. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides. J Nutr Biochem 2015;26:227-33. [PMID: 25498760 DOI: 10.1016/j.jnutbio.2014.10.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
616 Thoene-Reineke C, Fischer A, Friese C, Briesemeister D, Göbel UB, Kammertoens T, Bereswill S, Heimesaat MM. Composition of intestinal microbiota in immune-deficient mice kept in three different housing conditions. PLoS One 2014;9:e113406. [PMID: 25401702 DOI: 10.1371/journal.pone.0113406] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
617 Bringiotti R, Ierardi E, Lovero R, Losurdo G, Leo AD, Principi M. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol 2014; 5(4): 550-559 [PMID: 25400998 DOI: 10.4291/wjgp.v5.i4.550] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
618 Bonneau J, Dumestre-Perard C, Rinaudo-Gaujous M, Genin C, Sparrow M, Roblin X, Paul S. Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. Autoimmun Rev. 2015;14:231-245. [PMID: 25462578 DOI: 10.1016/j.autrev.2014.11.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 5.5] [Reference Citation Analysis]
619 Patterson E, Marques TM, O'Sullivan O, Fitzgerald P, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Stanton C, Ross RP. Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology (Reading) 2015;161:182-93. [PMID: 25370749 DOI: 10.1099/mic.0.082610-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
620 Nagaraja V, Eslick GD. Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: A systematic review. World J Gastroenterol 2014; 20(40): 14527-14536 [PMID: 25356018 DOI: 10.3748/wjg.v20.i40.14527] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
621 Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
622 Sekirov I, Gill N, Jogova M, Tam N, Robertson M, de Llanos R, Li Y, Finlay BB. Salmonella SPI-1-mediated neutrophil recruitment during enteric colitis is associated with reduction and alteration in intestinal microbiota. Gut Microbes 2010;1:30-41. [PMID: 21327114 DOI: 10.4161/gmic.1.1.10950] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
623 Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB. Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. J Immunol. 2014;193:5249-5263. [PMID: 25339668 DOI: 10.4049/jimmunol.1302832] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
624 Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Self Nonself. 2010;1:299-309. [PMID: 21487504 DOI: 10.4161/self.1.4.13560] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 15.3] [Reference Citation Analysis]
625 Zhang HX, Wang ZT, Lu XX, Wang YG, Zhong J, Liu J. NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population. Inflamm Res. 2014;63:979-985. [PMID: 25297810 DOI: 10.1007/s00011-014-0774-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
626 Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Taylor K, Prescott NJ, Murrells T, Stagg AJ, Whelan K, Lindsay JO. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Gut 2014;63:1578-86. [PMID: 24398881 DOI: 10.1136/gutjnl-2013-306226] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 11.0] [Reference Citation Analysis]
627 Holtz LR, Cao S, Zhao G, Bauer IK, Denno DM, Klein EJ, Antonio M, Stine OC, Snelling TL, Kirkwood CD. Geographic variation in the eukaryotic virome of human diarrhea. Virology. 2014;468-470:556-564. [PMID: 25262473 DOI: 10.1016/j.virol.2014.09.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
628 Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, Parameswaran N, McCabe LR. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014;229:1822-1830. [PMID: 24677054 DOI: 10.1002/jcp.24636] [Cited by in Crossref: 223] [Cited by in F6Publishing: 224] [Article Influence: 27.9] [Reference Citation Analysis]
629 Neish AS. Mucosal immunity and the microbiome. Ann Am Thorac Soc 2014;11 Suppl 1:S28-32. [PMID: 24437401 DOI: 10.1513/AnnalsATS.201306-161MG] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
630 Hart AL, Hendy P. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre. Proc Nutr Soc. 2014;73:452-456. [PMID: 25221893 DOI: 10.1017/s0029665114001153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
631 Carrière J, Darfeuille-Michaud A, Nguyen HTT. Infectious etiopathogenesis of Crohn’s disease. World J Gastroenterol 2014; 20(34): 12102-12117 [PMID: 25232246 DOI: 10.3748/wjg.v20.i34.12102] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
632 Orel R, Kamhi Trop T. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World J Gastroenterol 2014; 20(33): 11505-11524 [PMID: 25206258 DOI: 10.3748/wjg.v20.i33.11505] [Cited by in CrossRef: 113] [Cited by in F6Publishing: 92] [Article Influence: 14.1] [Reference Citation Analysis]
633 Perez-Chanona E, Mühlbauer M, Jobin C. The microbiota protects against ischemia/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling. Am J Pathol. 2014;184:2965-2975. [PMID: 25204845 DOI: 10.1016/j.ajpath.2014.07.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
634 Backert I, Koralov SB, Wirtz S, Kitowski V, Billmeier U, Martini E, Hofmann K, Hildner K, Wittkopf N, Brecht K, Waldner M, Rajewsky K, Neurath MF, Becker C, Neufert C. STAT3 Activation in Th17 and Th22 Cells Controls IL-22–Mediated Epithelial Host Defense during Infectious Colitis. J I 2014;193:3779-91. [DOI: 10.4049/jimmunol.1303076] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
635 Polymeros D, Tsiamoulos ZP, Koutsoumpas AL, Smyk DS, Mytilinaiou MG, Triantafyllou K, Bogdanos DP, Ladas SD. Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease. BMC Med 2014;12:139. [PMID: 25168804 DOI: 10.1186/s12916-014-0139-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
636 Brotherton CS, Taylor AG. Dietary fiber information for individuals with Crohn disease: reports of gastrointestinal effects. Gastroenterol Nurs 2013;36:320-7. [PMID: 24084130 DOI: 10.1097/SGA.0b013e3182a67a9a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
637 Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, Takeyama N, Kamioka M, Sakamoto M, Matsuki T, Setoyama H, Imaoka A, Uematsu S, Akira S, Domino SE, Kulig P, Becher B, Renauld JC, Sasakawa C, Umesaki Y, Benno Y, Kiyono H. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 2014;345:1254009. [PMID: 25214634 DOI: 10.1126/science.1254009] [Cited by in Crossref: 322] [Cited by in F6Publishing: 308] [Article Influence: 40.3] [Reference Citation Analysis]
638 Heimesaat MM, Dunay IR, Alutis M, Fischer A, Möhle L, Göbel UB, Kühl AA, Bereswill S. Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis. PLoS One 2014;9:e105120. [PMID: 25141224 DOI: 10.1371/journal.pone.0105120] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
639 Martinez-Medina M, Garcia-Gil LJ. Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity. World J Gastrointest Pathophysiol 2014; 5(3): 213-227 [PMID: 25133024 DOI: 10.4291/wjgp.v5.i3.213] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 105] [Article Influence: 14.3] [Reference Citation Analysis]
640 Ryan BM, Wolff RK, Valeri N, Khan M, Robinson D, Paone A, Bowman ED, Lundgreen A, Caan B, Potter J. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol. 2014;38:583-590. [PMID: 25132422 DOI: 10.1016/j.canep.2014.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
641 Hofmann C, Dunger N, Doser K, Lippert E, Siller S, Edinger M, Falk W, Obermeier F. Physiologic TLR9-CpG-DNA interaction is essential for the homeostasis of the intestinal immune system. Inflamm Bowel Dis 2014;20:136-43. [PMID: 24247649 DOI: 10.1097/01.MIB.0000436276.19755.c1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
642 Steinbach EC, Plevy SE. The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis. 2014;20:166-175. [PMID: 23974993 DOI: 10.1097/mib.0b013e3182a69dca] [Cited by in Crossref: 150] [Cited by in F6Publishing: 98] [Article Influence: 18.8] [Reference Citation Analysis]
643 Jing X, Zulfiqar F, Park SY, Núñez G, Dziarski R, Gupta D. Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis. J Immunol 2014;193:3055-69. [PMID: 25114103 DOI: 10.4049/jimmunol.1301548] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
644 Tahara T, Shibata T, Kawamura T, Okubo M, Ichikawa Y, Sumi K, Miyata M, Ishizuka T, Nakamura M, Nagasaka M, Nakagawa Y, Ohmiya N, Arisawa T, Hirata I. Fusobacterium Detected in Colonic Biopsy and Clinicopathological Features of Ulcerative Colitis in Japan. Dig Dis Sci 2015;60:205-10. [DOI: 10.1007/s10620-014-3316-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
645 Mann ER, Li X. Intestinal antigen-presenting cells in mucosal immune homeostasis: Crosstalk between dendritic cells, macrophages and B-cells. World J Gastroenterol 2014; 20(29): 9653-9664 [PMID: 25110405 DOI: 10.3748/wjg.v20.i29.9653] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
646 Angriman I, Scarpa M, Castagliuolo I. Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. World J Gastroenterol 2014; 20(29): 9665-9674 [PMID: 25110406 DOI: 10.3748/wjg.v20.i29.9665] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
647 Lutz P, Berger C, Langhans B, Grünhage F, Appenrodt B, Nattermann J, Lammert F, Hoerauf A, Sauerbruch T, Strassburg CP. A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis. Dig Liver Dis. 2014;46:1047-1050. [PMID: 25086996 DOI: 10.1016/j.dld.2014.07.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
648 Han DS. Current status and prospects of intestinal microbiome studies. Intest Res 2014;12:178-83. [PMID: 25349591 DOI: 10.5217/ir.2014.12.3.178] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
649 Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy. 2013;5:1357-1366. [PMID: 24283846 DOI: 10.2217/imt.13.130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
650 Zhang H, Xue Y, Wang H, Huang Y, Du M, Yang Q, Zhu MJ. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. World J Gastroenterol 2014; 20(27): 9106-9115 [PMID: 25083083 DOI: 10.3748/wjg.v20.i27.9106] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
651 de Silva PS, Luben R, Shrestha SS, Khaw KT, Hart AR. Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries. Eur J Gastroenterol Hepatol. 2014;26:11-18. [PMID: 24216567 DOI: 10.1097/meg.0b013e328365c372] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
652 Sohn MB, An L, Pookhao N, Li Q. Accurate genome relative abundance estimation for closely related species in a metagenomic sample. BMC Bioinformatics 2014;15:242. [PMID: 25027647 DOI: 10.1186/1471-2105-15-242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
653 Galley JD, Nelson MC, Yu Z, Dowd SE, Walter J, Kumar PS, Lyte M, Bailey MT. Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol. 2014;14:189. [PMID: 25028050 DOI: 10.1186/1471-2180-14-189] [Cited by in Crossref: 178] [Cited by in F6Publishing: 168] [Article Influence: 22.3] [Reference Citation Analysis]
654 Steppe M, Van Nieuwerburgh F, Vercauteren G, Boyen F, Eeckhaut V, Deforce D, Haesebrouck F, Ducatelle R, Van Immerseel F. Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing.Food Chem Toxicol. 2014;72:129-137. [PMID: 25007784 DOI: 10.1016/j.fct.2014.06.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
655 Bruce A, Black M, Bhattacharya S. Mode of Delivery and Risk of Inflammatory Bowel Disease in the Offspring: Systematic Review and Meta-analysis of Observational Studies. Inflammatory Bowel Diseases 2014;20:1217-26. [DOI: 10.1097/mib.0000000000000075] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
656 Allen-Vercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett. 2014;162:54-61. [PMID: 24972311 DOI: 10.1016/j.imlet.2014.05.014] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 8.9] [Reference Citation Analysis]
657 Magnusson MK, Wick MJ. Intestinal dendritic cell and macrophage subsets: Tipping the balance to Crohn's disease? Eur J Microbiol Immunol (Bp) 2011;1:19-24. [PMID: 24466433 DOI: 10.1556/EuJMI.1.2011.1.5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
658 Nakanishi Y, Sato T, Ohteki T. Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Mucosal Immunol. 2015;8:152-160. [PMID: 24938744 DOI: 10.1038/mi.2014.53] [Cited by in Crossref: 52] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
659 Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL;  ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014;8:1351-1361. [PMID: 24951261 DOI: 10.1016/j.crohns.2014.05.006] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
660 Li Y, Tian Y, Zhu W, Gong J, Gu L, Zhang W, Guo Z, Li N, Li J. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 2014;49:834-44. [DOI: 10.3109/00365521.2014.910834] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
661 Ardita CS, Mercante JW, Kwon YM, Luo L, Crawford ME, Powell DN, Jones RM, Neish AS. Epithelial adhesion mediated by pilin SpaC is required for Lactobacillus rhamnosus GG-induced cellular responses. Appl Environ Microbiol 2014;80:5068-77. [PMID: 24928883 DOI: 10.1128/AEM.01039-14] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
662 Bereswill S, Kühl AA, Alutis M, Fischer A, Möhle L, Struck D, Liesenfeld O, Göbel UB, Dunay IR, Heimesaat MM. The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis. Gut Pathog 2014;6:19. [PMID: 24932221 DOI: 10.1186/1757-4749-6-19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
663 Ye H, Wu Q, Zhu Y, Guo C, Zheng X. Ginsenoside Rh2 alleviates dextran sulfate sodium-induced colitis via augmenting TGFβ signaling. Mol Biol Rep 2014;41:5485-90. [PMID: 24893598 DOI: 10.1007/s11033-014-3422-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
664 Bjerrum JT, Wang Y, Hao F, Coskun M, Ludwig C, Günther U, Nielsen OH. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics 2015;11:122-33. [PMID: 25598765 DOI: 10.1007/s11306-014-0677-3] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 15.5] [Reference Citation Analysis]
665 Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci. 2014;15:9594-9627. [PMID: 24886810 DOI: 10.3390/ijms15069594] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
666 Burberry A, Zeng MY, Ding L, Wicks I, Inohara N, Morrison SJ, Núñez G. Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling. Cell Host Microbe 2014;15:779-91. [PMID: 24882704 DOI: 10.1016/j.chom.2014.05.004] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 12.5] [Reference Citation Analysis]
667 McPhee JB, Small CL, Reid-Yu SA, Brannon JR, Le Moual H, Coombes BK. Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli. Infect Immun 2014;82:3383-93. [PMID: 24866805 DOI: 10.1128/IAI.01888-14] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
668 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
669 Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, Ringel Y. Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther. 2014;40:200-207. [PMID: 24853043 DOI: 10.1111/apt.12800] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
670 Nagar J, Ranade S, Kamath V, Singh S, Karunanithi P, Subramani S, Venkatesh K, Srivastava R, Dudhgaonkar S, Vikramadithyan RK. Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease. Int Immunopharmacol 2014;21:328-35. [PMID: 24859061 DOI: 10.1016/j.intimp.2014.05.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
671 Gerasimidis K, Bertz M, Hanske L, Junick J, Biskou O, Aguilera M, Garrick V, Russell RK, Blaut M, Mcgrogan P, Edwards CA. Changes in dominant gut microbial species and metabolites in children with Crohn's disease during exclusive enteral nutrition. Proc Nutr Soc 2014;73. [DOI: 10.1017/s0029665114000470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
672 Lu L, Chan RL, Luo XM, Wu WK, Shin VY, Cho CH. Animal models of gastrointestinal inflammation and cancer. Life Sci 2014;108:1-6. [PMID: 24825611 DOI: 10.1016/j.lfs.2014.04.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
673 Dibra D, Mishra L, Li S. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship. Biochim Biophys Acta 2014;1846:152-60. [PMID: 24821201 DOI: 10.1016/j.bbcan.2014.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
674 Barzegari A, Saeedi N, Saei AA. Shrinkage of the human core microbiome and a proposal for launching microbiome biobanks. Future Microbiology 2014;9:639-56. [DOI: 10.2217/fmb.14.22] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
675 Obata Y, Furusawa Y, Endo TA, Sharif J, Takahashi D, Atarashi K, Nakayama M, Onawa S, Fujimura Y, Takahashi M, Ikawa T, Otsubo T, Kawamura YI, Dohi T, Tajima S, Masumoto H, Ohara O, Honda K, Hori S, Ohno H, Koseki H, Hase K. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat Immunol 2014;15:571-9. [PMID: 24777532 DOI: 10.1038/ni.2886] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 13.9] [Reference Citation Analysis]
676 Principato M, Qian BF. Staphylococcal enterotoxins in the etiopathogenesis of mucosal autoimmunity within the gastrointestinal tract. Toxins (Basel) 2014;6:1471-89. [PMID: 24776983 DOI: 10.3390/toxins6051471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
677 Garagnani P, Pirazzini C, Giuliani C, Candela M, Brigidi P, Sevini F, Luiselli D, Bacalini MG, Salvioli S, Capri M, Monti D, Mari D, Collino S, Delledonne M, Descombes P, Franceschi C. The three genetics (nuclear DNA, mitochondrial DNA, and gut microbiome) of longevity in humans considered as metaorganisms. Biomed Res Int 2014;2014:560340. [PMID: 24868529 DOI: 10.1155/2014/560340] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
678 Assa A, Vong L, Pinnell LJ, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis. 2014;210:1296-1305. [PMID: 24755435 DOI: 10.1093/infdis/jiu235] [Cited by in Crossref: 119] [Cited by in F6Publishing: 122] [Article Influence: 14.9] [Reference Citation Analysis]
679 D'Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inflammatory bowel disease management. J Crohns Colitis. 2014;8:726-734. [PMID: 24742736 DOI: 10.1016/j.crohns.2014.02.025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 8.3] [Reference Citation Analysis]
680 Allegretti JR, Hamilton MJ. Restoring the gut microbiome for the treatment of inflammatory bowel diseases. World J Gastroenterol 2014; 20(13): 3468-3474 [PMID: 24707129 DOI: 10.3748/wjg.v20.i13.3468] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
681 Yu G, Gail MH, Shi J, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ, Wei WQ, Fan JH, Qiao YL, Dawsey SM, Freedman ND, Abnet CC. Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach. Cancer Epidemiol Biomarkers Prev 2014;23:735-41. [PMID: 24700175 DOI: 10.1158/1055-9965.EPI-13-0855] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
682 Namatovu F, Sandström O, Olsson C, Lindkvist M, Ivarsson A. Celiac disease risk varies between birth cohorts, generating hypotheses about causality: evidence from 36 years of population-based follow-up. BMC Gastroenterol 2014;14:59. [PMID: 24693975 DOI: 10.1186/1471-230X-14-59] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
683 Kasinathan NK, Subramaniya BR, Pandian I, Sivasithamparam ND. Aegle marmelos fruit extract abates dextran sodium sulfate induced acute colitis in mice: Repression of pro-inflammatory cytokines during colonic inflammation. Biomedicine & Preventive Nutrition 2014;4:307-17. [DOI: 10.1016/j.bionut.2014.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
684 Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med. 2014;9:365-373. [PMID: 24664520 DOI: 10.1007/s11739-014-1069-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 7.9] [Reference Citation Analysis]
685 Vaarala O. Human intestinal microbiota and type 1 diabetes. Curr Diab Rep 2013;13:601-7. [PMID: 23934614 DOI: 10.1007/s11892-013-0409-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
686 Perez-Muñoz ME, Bergstrom K, Peng V, Schmaltz R, Jimenez-Cardona R, Marsteller N, McGee S, Clavel T, Ley R, Fu J, Xia L, Peterson DA. Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. Gut Microbes 2014;5:286-95. [PMID: 24662098 DOI: 10.4161/gmic.28622] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
687 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol. 2014;49:785-798. [PMID: 24652102 DOI: 10.1007/s00535-014-0953-z] [Cited by in Crossref: 139] [Cited by in F6Publishing: 124] [Article Influence: 17.4] [Reference Citation Analysis]
688 Eun CS, Mishima Y, Wohlgemuth S, Liu B, Bower M, Carroll IM, Sartor RB. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect Immun 2014;82:2239-46. [PMID: 24643531 DOI: 10.1128/IAI.01513-13] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 8.9] [Reference Citation Analysis]
689 Andoh A, Kobayashi T, Kuzuoka H, Tsujikawa T, Suzuki Y, Hirai F, Matsui T, Nakamura S, Matsumoto T, Fujiyama Y. Characterization of gut microbiota profiles by disease activity in patients with Crohn's disease using data mining analysis of terminal restriction fragment length polymorphisms. Biomed Rep 2014;2:370-3. [PMID: 24748976 DOI: 10.3892/br.2014.252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
690 Walton C, Fowler DP, Turner C, Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Cole JA. Analysis of volatile organic compounds of bacterial origin in chronic gastrointestinal diseases. Inflamm Bowel Dis. 2013;19:2069-2078. [PMID: 23867873 DOI: 10.1097/mib.0b013e31829a91f6] [Cited by in Crossref: 63] [Cited by in F6Publishin